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ABSTRACT 
 
Spermatogenesis is a complex process requiring not only hormonal regulation but also a 
large number of well-orchestrated paracrine and autocrine mechanisms that control cell 
proliferation and differentiation. This thesis presents my work on glial cell line-derived 
neurotrophic factor (GDNF) and neurturin (NRTN) in spermatogenesis and the 
pathogenesis of germ line tumours. 
 
GDNF is a multifunctional molecule during embryogenesis and in some adult tissues. In 
the testis, Sertoli cells express GDNF while spermatogonial cells, the undifferentiated 
germ cells, express the GDNF receptors, Ret and GDNF family receptor α1 (GFRα1). A 
factor homologous to GDNF, NRTN, is also expressed by Sertoli cells, while its ligand 
binding coreceptor GFRα2 is expressed prominently by spermatids and weakly by 
spermatocytes. These expression patterns suggest that GDNF and NRTN could be 
paracrine regulators of germ cell development. 
 
To approach the functions of GDNF and NRTN in spermatogenesis I used transgenic 
mouse models. Due to the early lethality of GDNF-deficient mice in the first postnatal 
day, spermatogenesis was analysed in heterozygous (GDNF+/-) mice. The transgenic 
mice with testis-specific overexpression of GDNF and NTRN were generated under the 
human elongation factor 1α (EF-1α) promoter. The dosage of GDNF regulates cell fate 
decision of undifferentiated spermatogonia, as the low dosage in GDNF+/- mice leads to 
the depletion of spermatogenic cells, whereas overexpression of GDNF promotes self-
renewal of spermatogonial stem cells. By transplanting GDNF-expressing cells to 
irradiated wild type testes, the arrest of differentiation is shown to be cell-autonomous. 
GDNF-expressing spermatogonia do not differentiate in the new host, but are capable of 
repopulating the seminiferous tubules. Testis tumours frequently develop in transgenic 
mice with testes-specific overexpression of GDNF. We found high activity of AKT 
(protein kinase B) in the downstream pathway of GDNF/Ret signalling that may be 
essential for the formation of testicular tumours. Characteristics of these tumours 
represent the first transgenic model for human seminoma. Our data from the testis-
specific overexpression of NRTN and GDNF suggest that NRTN and GDNF have 
different functions. NRTN may have a role in the regulating of the maintenance and 
development of spermatocytes and spermatids, and the fluid production or reabsorption 
of seminiferous tubules.  
 
This GDNF-overexpressing transgenic mouse line serves as a powerful tool to study the 
pathogenesis of seminoma and to test novel therapies and diagnostic methods. Excessive 
stem cell self-renewal in the presence of a high GDNF dosage suggests that GDNF may 
also be useful in vitro for multiplying the stem cell population prior to germ cell 
transplantation, which might be beneficial for the patients who need to cryopreserve 
spermatogonic cells prior to oncogenic therapy. 
 
Key words: GDNF, NRTN, Ret, GFRα, AKT, testis, spermatogenesis, seminoma, 
transplantation. 
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1. REVIEW OF THE LITERATURE 
 
1.1 Testicular germ cell development 
 
1.1.1 Spermatogenic cells of the foetal and prepuberal mouse 
 
Primordial germ cells (PGCs), the common germ cell lineage in both male and female 
embryos, are derived from a small population of the epiblast adjacent to the extra-
embryonic ectoderm cells in mouse at embryonic day 6.0 (E6.0) (Lawson and Hage 
1994). PGCs are recognisable owing to their staining for alkaline phosphatase at E7.25 
(Ginzburg et al. 1990). Subsequently, proliferating PGCs migrate from the base of the 
allantois along the hindgut to the genital ridges at E10.5-11.5. There they must make a 
big decision: to be in mitosis or meiosis, to become sperm or egg? The PGCs differentiate 
into precursor cells of either male or female gametes under the control of cell-cell 
interactions in the developing gonad (Gilbert 2000). The first stage in testis development 
is the initiation of testis cord formation at approximately E12.0 (Tilmann et al. 1999), 
when PGCs commit to become the precursors of male gametes. Then the PGCs become 
enclosed by supporting somatic cells, the precursor Sertoli cells. When the PGCs are 
enclosed in seminiferous cords they change morphologically and are called gonocytes, 
sometimes prospermatogonia, which are centrally located within the seminiferous cords. 
The gonocytes proliferate for a few days and then arrest in the G0/1 phase of the cell cycle 
until soon after birth (Peters 1970). The gonocytes resume proliferation and migrate to 
establish contacts with the basement membrane of seminiferous tubules within a few days 
after birth and to give rise to adult type spermatogonia (Orth et al. 1997). 
 
In postnatal day 6, the seminiferous epithelia contain only primitive type A 
spermatogonia and Sertoli cells. Type A and type B spermatogonia are present by day 8. 
At day 10, meiotic prophase is initiated. The germ cells reach the early and late pachytene 
stages by days 14 and 18, respectively. Secondary spermatocytes and haploid spermatids 
appear in increasing numbers between days 18 and 20 (Bellvé et al. 1977), thereby 
signifying the onset of spermatogenesis. The seminiferous cord has acquired a lumen in 
many areas by day 16, when the Sertoli tight junction (blood-testis barrier) is formed 
(Bellvé et al. 1977). The occluding Sertoli cell junctions are the major structural 
components of the blood-testis barrier (Gilula et al. 1976; Byers et al. 1991). The 
appearance of a lumen in many areas of the seminiferous cords at this time indicates the 
impermeability of the Sertoli junctions. With maturation of the tight junctions, the 
seminiferous epithelium is effectively divided into two compartments. The basal 
compartment in which the spermatogonia and early primary spermatocytes reside, and the 
adluminal compartment in which the more advanced spermatocytes and spermatids are 
secluded (Dym 1973; Byers et al. 1991; Pelletier and Byers 1992). This barrier creates a 
unique microenvironment in which germ cells except spermatogonia and early 
spermatocytes are segregated from the systemic circulation.  
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1.1.2 The adult testis 
 
In the seminiferous tubules the Sertoli cells support the developing germ cells. The tight 
junctions between the Sertoli cells provide a blood-testis barrier, resulting in tubular 
lumen and fluid having quite a different composition from plasma (Bellvé et al. 1977; 
Gilula et al. 1976; Byers et al. 1991). The interstitial space between the capillary 
endothelium and tight junctions of seminiferous tubule contains substances and nutrients 
for Leydig cells. Leydig cells produce the major male sex hormone, testosterone. 
Peritubular myoid cells surround the seminiferous tubule and are in contact with the basal 
surface of Sertoli cells. Cell-cell interactions between all three somatic cell types are 
possible (Fig. 1; Parvinen et al. 1982; Skinner 1991; Gnessi et al. 1997). However, Sertoli 
cells appear to be the primary somatic cell type to directly interact with the developing 
germ cells. 
 
 
LC PC
SC GC
IL-1, FGF2, TGF-   , TGF-α β TGF-   , TGF-α β
LH
FSH
Androgen
Androgen
Estrogen?
TGF-   , TGF-
IGF I
α β
TGF-   , IGFβ
IL-1, IGF, SCF, Activin?
Inhibin?
NGF?, FGF2?
EGF, FGF2 EGF
PDGF
 
 
 
Figure 1. Cell types and some examples of their interactions in adult testis. Cell 
types: GC, germ cells; LC, Leydig cell; PC, peritubular cell; SC, Sertoli cell. Potential 
local factors: EGF, epidermal growth factor; FGF2, fibroblast growth factor2; FSH, 
follicle-stimulating hormone; IGF, insulin-like growth factor; IL, interleukin; LH, 
luteinizing hormone;  NGF, nerve growth factor; PDGF, platelet-derived growth factor; 
SCF, stem cell factor; TGF, transforming growth factor.  
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1.1.3 Spermatogenesis  
 
In mammals spermatogenesis occurs within seminiferous tubules that release 
spermatozoa into the rete testes, which connect the seminiferous tubules to the 
epididymis. The process in which spermatogonia form spermatozoa is called 
spermatogenesis. This complex process involves a series of mitotic divisions of 
spermatogonial cells, two meiotic divisions of spermatocytes, extensive morphological 
remodelling of the spermatids during spermiogenesis, and the release of the maturing 
spermatozoa into lumen by spermiation. In the mouse, the entire developmental process 
from stem cell to spermatozoon takes 34.5 days. The spermatogonial stage lasts 8 days, 
meiosis lasts 13 days, and spermiogenesis takes up another 13.5 days (Clermont 1972). 
The spermatogonial stem cells are capable of self-renewal and commitment of 
differentiation and, therefore, spermatogenesis continues via a cyclic process during the 
life of the male. The precise combinations of various generations of spermatocytes and 
spermatids derived from individual spermatogonia reflect waves of spermatogenesis that 
are not random but instead occur in a specific cyclic manner referred to as stages (Russell 
et al. 1990). The succession of these stages of germ cells is referred to as a cycle of the 
seminiferous epithelium (Russell 1990). 
 
1.1.3.1 Mitotic phase of spermatogenesis 
 
A. Stem cells and undifferentiated spermatogonia 
 
During the proliferative phase, spermatogonial stem cells in the basal compartment of 
seminiferous tubules undergo mitotic divisions giving rise to both new stem cells and 
committed precursors that continue to divide and differentiate into spermatocytes. In 
mammals spermatogonial stem cells are A single (As) spermatogonia that either renew 
themselves or produce A paired (Apr) spermatogonia destined to differentiate (Huckins 
1971a,b; Oakberg 1971; Lok et al. 1983; de Rooij 2001). In turn, the Apr divides into 
chains of A aligned (Aal) spermatogonia that undergo mitotic divisions but remain as a 
syncitium through the intercellular cytoplasmic bridges (Fig. 2) (reviewed by de Rooij 
2001). As, Apr and Aal compose the undifferentiated spermatogonia. 
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As
Apr
Aal-4
Aal-8
 
 
Figure 2. The divisions and differentiation of undifferentiated spermatogonial cells. 
Note: As, A single spermatogonia; Apr, A paired spermatogonia; Aal, A aligned 
spermatogonial cells; numbers 4 and 8 refer to the cell number of the interconnected 
spermatogonial chain. 
 
Two possible mechanisms for spermatogonial stem cell renewal and commitment 
towards differentiation have been presented (Fig. 3) (Reviewed by de Rooij 2001). The 
commonly favoured symmetric division theory implies that a stem cell gives rise to either 
two stem cells or two Apr spermatogonia. The asymmetric division theory suggests that 
the stem cell, through an asymmetric division, produces a new stem cell and another "As" 
that is destined to Apr differentiation and, therefore, this "As" cell is no longer a true 
stem cell. Only little evidence for the possibility of asymmetric division has been 
presented. In rat, some As spermatogonia retain incorporated 3-(H) thymidine for a very 
long time, indicating that these cells have a very long cycle while other As spermatogonia 
lose their label more quickly. It was proposed that the long-cycling cells are true stem 
cells and the short-cycling cells are destined to become Apr spermatogonia (Huchins 
1971b).  
 
How to keep a stem cell as a stem cell? Very little is known about the answer. After 
severe cell damage, stem cell renewal is favoured over differentiation and the period of at 
least As, Apr, and Aal spermatogonia is extended (Van Beek et al. 1990; de Rooij 2001). 
After exposure to irradiation and toxic substances, spermatogonia and some of the stem 
cells undergo degeneration leading to germ cell depletion. The surviving spermatogonial 
stem cells repopulate the seminiferous epithelia, and initially stem cells renewal overrides 
differentiation. During the first six divisions after irradiation stem cells virtually only 
self-renew (Van Beek et al. 1990). This finding suggests that there must be a regulatory 
mechanism controlling the cell fate decision of stem cells. In normal seminiferous 
epithelia, the ratio between self-renewal and differentiation of spermatogonia should be 
about 1:1 (Reviewed by de Rooij 2001). More self-renewal than differentiation of stem 
cells would reduce the seminiferous epithelia and may raise the risk of germ cell tumours. 
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If differentiation overrides, the stem cell pool is consumed and may vanish, resulting in 
Sertoli cell-only seminiferous tubules.  
 
As
As
As
As AprApr
Symmetrical stem cell divisions Asymmetrical stem cell divisions
As
As
As
'As'
'As'
AprApr
 
 
Figure 3. Two hypothetical models for stem cell self-renewal and differentiation. 
Modified according to de Rooij 2001. 
 
B. Differentiating spermatogonia 
 
The last generation of undifferentiated spermatogonia, Aal spermatogonia do not divide 
but differentiate to A1 spermatogonia. Few Apr, and even fewer As spermatogonia can 
also differentiate to A1 (reviewed by de Rooij 2000). C-kit, Dazl RNA protein, cyclin 
D2, and retinoic acid have been implicated in this differentiation step (reviewed by de 
Rooij 2001). Spermatogonia further undergo six mitotic divisions resulting in generations 
of more differentiated spermatogonia: A2 to A4 spermatogonia, intermediate 
spermatogonia, and type B spermatogonia that divide and give rise to prophase 
spermatocyte proleptotene (Fig. 4). A1, A2, A3, A4, In, and B spermatogonia are 
grouped to differentiating spermatogonia (reviewed by de Rooij and Russell 2000; de 
Rooij 2001).  
 
The lack of fine regulation of the density of spermatogonial stem cells results in an 
uneven density of A1 spermatogonia distribution in different segments of seminiferous 
tubules. An equal density of spermatocytes is obtained by apoptosis of A2, A3 or A4 
spermatogonia to remove the surplus cells. Germ cell apoptosis plays an important role in 
limiting the density of germ cells thus guaranteeing their optimal development, and 
Sertoli cells have been shown actively controlling the number of germ cells (de Rooij and 
Loc 1987; Lee et al. 1997).  
 
As Apr Aal4 Aal8 A1 A2 A3 A4 In B
mmmmmmmm
N
o 
M
ito
si
s
 
 
Figure 4. Progression of spermatogonial divisions. According to de Rooij and Russell, 
2000. m: mitosis. 
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C. Spermatogonial transplantation 
 
The proliferatively active spermatogonial stem cells offer a potential to restore 
spermatogenesis by stem cell transplantation. Germ cell transplantation is an important 
tool in restoring fertility, for generating a genetically modified male germ line, and also 
as a research tool for germ cell biology. The pioneer work in the development of the 
technique using microinjection to introduce the donor cells into seminiferous tubules was 
performed by Brinster and Zimmermann (1994) and Brinster and Avarbock (1994). As an 
alternative to intratubular infusion of germ cells by microinjection, injections into 
efferent ducts as well as into the rete testis of the host mice have been successfully 
employed (Ogawa et al. 1997).  
 
The ability to cryopreserve donor germ cells for a long period of time prior to the 
transplantation has been established (Avarbock et al. 1996; Nagano and Brinster 1998). 
The transplantation of spermatogonial stem cells cultured for four months has also been 
successful (Nagano et al. 1998). Therefore, these techniques provide possibilities for 
multiplication and manipulation of male germ line cells, and also provide the clinical 
possibility to reintroduce the preserved germ cells after cancer therapies into the male 
gonad that has been damaged by the therapy.  
 
Electron microscopy of the host testes has shown focal arrangements of quantitatively 
and qualitatively normal donor spermatogenesis in the transplanted testis (Russell et al. 
1996). A time course study after transplantation showed that most transplanted cells 
degenerate and disappear from the testis during the first few weeks (Parreira et al. 1998). 
The first meiotic donor germ cells appear one month after transplantation and after two 
months only 1% of all seminiferous tubules contain meiotic germ cells. The xenogenetic 
transfer of germ cells between species has shown that the donor spermatogonia are able 
to repopulate the basal compartment of the host seminiferous tubules. Some of the host 
species can support normal or abnormal donor spermatogenesis, some do not allow the 
xenogenetic donor germ cell differentiation at all (reviewed by Ogawa 2001).  
 
There are several important new findings arising from experiments using germ cell 
transplantation. First, it became obvious that the blood-testis barrier of the adult testis 
does not hinder the migration of transplanted spermatogonia cells from the adluminal 
compartment to the basal compartment of the seminiferous epithelium. Second, the 
appearance of sperm in w/w mutant mice arising from the donor spermatogonia revealed 
that germ cells without functional c-kit receptors are not able to enter the process of 
spermatogenesis (Brinster and Zimmermann 1994).  
 
1.1.3.2 Meiotic phase of spermatogenesis 
 
The last mitotic division of spermatogonia (B spermatogonia) gives rise to the young 
spermatocyte, the preleptotene spermatocyte. During the prophase, the nuclei of cells 
increase in size. The preleptotene spermatocyte progresses into leptotene, zygotene, 
pachytene, and diplotene primary spermatocytes that undergo the meiotic DNA 
replication and recombination of homologous chromosomes and two meiotic divisions. 
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In the preleptene-leptotene transition, the cells move from basal compartment towards the 
adluminal compartment of the blood-testis barrier. In the leptotene phase, the 
homologous chromosomes become condensed but remain unpaired. The meiotic 
recombination begins before chromosome synapsis at the sites of double strand breaks 
form at early meiotic prophase (Hawley and Arbel 1993). In the zygotene phase, the 
synapsis of homologous chromosome occurs and produces the structure called the 
synaptonemal complex, which is fully formed by the late pachytene phase. In pachytene 
cells, the chromosomes have become fully paired and remain so for a long time (in 
mammals typically 1.5-2 weeks). Genetic recombination known as crossing over also 
occurs during this period. The diplotene phase is rather brief. In the diplotene phase, the 
synaptonemal complex dissipates and chromosomes separate from each other except at 
the regions of chiasmata. The metaphase, anaphase and telephase are referred to as the 
first meiotic division, or meiosis I. The cells now become secondary spermatocytes which 
rapidly undergo the second meiotic division or meiosis II resulting in haploid spermatids 
(Russell et al. 1990).  
 
1.1.3.3 Spermiogenic phase of spermatogenesis 
 
During the third or spermiogenic phase, the early round spermatids transform without cell 
division into mature spermatozoa. This phase takes almost two weeks in mouse and can 
be divided into 16 steps according the morphological characteristics of the formation of 
the flagellum, acrosome, elongation and the condensation of the nucleus, as well as 
nuclear DNA packing (Russell et al. 1990). The elimination of the cytoplasm together 
with other changes results in the reduction of the volume of spermatids to approximately 
25% of their original size.  
 
The final maturation and capacitation of sperm take place in the epididymal ducts, which 
develops from the cranial mesonephros during embryogenesis. Growth factors and their 
receptors regulate the epithelial differentiation of the epididymal duct. Loss-of-function 
of bone morphogenetic protein-8a (Bmp-8a) leads to the degeneration of the epididymal 
epithelium (Zhao et al. 1998). Overexpression of vascular endothelial growth factor 
(VEGF) causes the dilation of the ductus epididymis with regional epithelial hyperplasia 
(Korpelainen et al. 1998). The inactivation of the c-Ros orphan receptor tyrosine kinase 
results in an abnormal epithelial differentiation in the cranial part of epididymis, and 
therefore causes male infertility (Sonnenberg-Riethmacher et al. 1996). The spermatids 
produced are conducted from the seminiferous tubules to the epididymis by the fluid 
floating through the tubular lumen, rete testis, and efferent ducts to the epididymis. The 
effect of the inefficient fluid reabsorption or excessive production may result in 
infertility. The estrogen receptor knockout (ERKO) mice are infertile due to the problem 
of fluid reabsorption in the efferent ductules, and to a lesser extent, in the initial segment 
of the epididymis (Eddy et al. 1996; Hess et al. 1997).  
 
1.1.4 The impact of Sertoli cells  
 
The Sertoli cell, the only somatic cell type within the seminiferous tubule, plays 
numerous essential roles in the regulation of spermatogenesis (Parvinen et al. 1982, 1986; 
reviewed by Russell and Griswold 1993). These range from the association of Sertoli 
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cells with germ cells and their structural role in the establishment of the blood-testis 
barrier to the importance of the paracrine regulation of germ cell differentiation 
(reviewed by Bardin et al. 1988; Skinner 1991; Gnessi et al. 1997). An individual Sertoli 
cell can be in contact with five adjacent Sertoli cells at the basal surface and 47 adjacent 
germ cells at various stages of development (Russell et al. 1983). The ability of an 
individual cell to be in contact with more than 50 adjacent cells indicates the importance 
of interactions between these cells. The Sertoli cell receives nutrition and signals from the 
circulatory system and surrounding cells, and then transports nutrients to germ cells and 
adjusts the input signals to mediate germ cell development by both paracrine products 
and modulating its own function. In addition, the Sertoli cell also has the functions of 
phagocytosis and pinocytosis to remove the dead cells (reviewed by Russell and 
Griswold 1993). 
 
1.1.5 Germ cell apoptosis during spermatogenesis 
 
Extensive cell death is a striking feature of spermatogenesis. Apoptosis occurs at a 
baseline level in adult testis, and 25 to 75% of the theoretically expected germ cell yield 
is lost during spermatogenesis (Oakberg 1956; Huckins 1978; de Rooij and loc 1987; 
Wang et al.1998a). In the postnatal murine testis, apoptosis is detected in spermatogonia 
and spermatocytes (Allan et al. 1987; Bartke 1995; Blanco-Rodriguez 1998; Embree and 
Boekelheide 2000). Apoptotic cell death plays an important role during development by 
regulating the size of the germ cell lineage in relation to its local environment, the 
survival itself being dependent upon the availability of local factors and their regulatory 
stimuli (de Rooij and Loc 1987; Lee et al. 1997; Conlon and Raff 1999). Sertoli cells 
actively limit the number of germ cells at least by producing death factors such as FasL, 
which signals germ cell death (Lee et al. 1997). It is also assumed that spermatogonia and 
spermatocytes with chromosomal abnormalities during replication and division might be 
eliminated through apoptosis by unknown mechanism(s) in order to keep the fidelity of 
the genome (Allan et al. 1987). In addition to the role of growth and survival factors in 
the development and maintenance of normal germ cell function, it has been increasingly 
evident that cell death is important for testicular homeostasis (Matsui 1998; Embree and 
Boekelheide 2000). Two separate transgenic mouse models overexpressing anti-apoptosis 
factors, either BclxL or Bcl2, in testis germ cells show severely abnormal 
spermatogenesis accompanied by sterility (Furuchi et al. 1996; Rodriguez et al. 1997). 
Moreover, spermatogenesis is impaired in null mice for the pro-apoptosis factor bax and 
they are characterised by atrophic testis and male infertility (Knudson et al. 1995). 
 
The regulatory mechanisms of germ cell apoptosis are still not fully understood. However 
several factors including the SCF/c-kit system, Fas/fas ligand system, Bcl-2 family 
proteins, and bone morphogenetic protein-8a or -8b (Bmp-8a or -8b) are involved in the 
regulation of germ cell apoptosis. Apoptosis can be triggered by the absence of a trophic 
signal, which normally promotes cell survival. For instance, gene disruption of Bmp-8a 
or -8b shows increased germ cell apoptosis (Zhao et al. 1996, 1998). c-kit and its ligand 
stem cell factor (SCF) are crucial for the survival of germ cells. The injection of a 
monoclonal antibody to c-kit to inhibit SCF binding to the receptor leads to decreased 
numbers of differentiating spermatogonia (Yoshinaga et al. 1991) and high levels of 
apoptosis in germ cells undergoing mitosis and meiosis (Packer et al. 1995). There have 
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also been a number of studies showing that withdrawal of follicle stimulating hormone 
(FSH) and testosterone stimulation of the testis results in apoptosis (reviewed by Sinha 
and Swerdloft et al. 1999). SCF levels are increased by FSH (Yan et al. 1999) and this 
decreases the number of germ cell undergoing apoptosis (Yan et al. 2000a,b). In vitro 
data showed the involvement of Bcl-2 and Bcl-w in germ cell apoptosis (Yan et al. 
2000c,d). Apoptosis is often a consequence of an arrest of germ cell differentiation 
(Nantel et al. 1996; Ashley 2000). Cell death can be induced by noxious agents or 
pathological conditions, for instance, ionising radiation, cytotoxic drugs, hyperthermia 
and ischaemia, and an over-load of tubular fluid (Allan et al. 1987; Eddy et al. 1996; Hess 
et al. 1997).  
 
1.1.6 Hormonal control of spermatogenesis 
 
Normal spermatogenesis requires a fully functional hypothalamo-hypophysial system 
(reviewed by Matsumoto 1989, 1991; Huhtaniemi and Toppari 1998). The two major 
pituitary gonadotropins, luteinizing hormone (LH) and FSH, are required for 
spermatogenesis (Finkel et al. 1985).  
 
LH indirectly regulates spermatogenesis via stimulating the testosterone (T) production 
of Leydig cells that have the receptor for LH (Catt et al. 1980). The high local 
concentration of T produced by Leydig cells binds to intracellular receptors located in 
Sertoli cells and peritubular myoid cells to regulate spermatogenesis (Sar et al. 1993). 
Most recently, two different research groups simultaneously generated LH receptor 
deficient mice which show a similar phenotype to the human patients with an inactivating 
LHR mutation (Beck-Peccoz et al. 2000; Zhang et al. 2001; Lei et al. 2001). 
Spermatogenesis in these mutant mice is arrested at the round spermatid stage and Leydig 
cell numbers are dramatically reduced (Zhang et al. 2001; Lei et al. 2001).  
 
The importance of FSH for the initiation of spermatogenesis has been challenged by 
several recent findings. First, in men with inactivating mutations of the FSH receptor 
gene, spermatogenesis proceeds to completion though sperm counts are low and testis 
size is reduced (Tapanainen et al. 1997). Second, spermatogenesis is complete in the FSH 
β-subunit deficient mice that were fertile. The testes in these mice are smaller with a 
decreased Sertoli cell number and low germ cell count (Kumar et al. 1997). Third, in the 
hypogonadotropic (hpg) mutant mouse that has undetectable levels of both LH and FSH, 
due to lack of gonadotropin-releasing hormone (GnRH), spermatogenesis can be initiated 
by T but it has a low sperm output (Singh et al. 1995). Despite these data, the concept that 
FSH plays critical roles in establishing normal spermatogenesis is reinforced by the 
following data. Many patients with Kallman’s syndrome cannot achieve normal 
spermatogenesis without using a combination of FSH and LH (reviewed by de Kretser et 
al. 2000). 
 
FSH binds to a specific G protein-coupled membrane receptor on Sertoli cells and 
controls spermatogenesis through regulation of Sertoli cell function (Griswold 1993). 
FSH plays a key role in controlling overall sperm production by stimulating Sertoli cell 
proliferation during the prenatal and postnatal period and by regulating the secretion of a 
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number of Sertoli cell products, e.g. androgen binding protein (ABP), transferrin, 
testibumin, inhibin, transforming growth factor-β (TGF-β), Müllerian inhibiting 
substance (MIS), insulin-like growth factor (IGF) binding protein 3, SCF, polyamines, 
plasminogen activators, lactate, and pyruvate during different periods of development 
(reviewed by Russell and Griswold 1993). The link between the classical hormonal 
regulation of spermatogenesis and SCF has been strengthened by the observation that 
SCF levels are increased by FSH (Yan et al. 1999). This stimulation is translated into 
increased numbers of germ cells (Yan et al. 2000a). These results provide an excellent 
example of how Sertoli cells transmit the hormonal regulation of spermatogenesis to 
germ cells. FSH may be a prerequisite of T action during development. Assuming that the 
effects of FSH and T are mediated by Sertoli cell, it has been suggested that the Sertoli 
cell is particularly vulnerable at certain times to the loss of hormonal stimulation. 
Meachem and co-workers (1998) showed that the neutralisation of FSH in vivo, using a 
polyclonal antibody against FSH, could impair the action of T in restoring 
spermatogenesis in the testosterone-estradiol suppressed or GnRH-immunised models.  
 
Although the importance of T in the maintenance of spermatogenesis is not disputed, 
evidence has been adduced from the outcome of mutations in the androgen receptor (AR) 
which can cause total or partial androgen insensitivity leading to a range of patterns of 
abnormal sexual differentiation (Quigley et al. 1995; Tut et al. 1997; Wang et al. 1998b; 
Dowsing et al. 1999). The hgp-mouse model of GnRH-deficiency proposed that the most 
T-sensitive step is the conversion of spermatocytes to spermatids (Singh et al. 1995). 
Both T and FSH stimulate the production of the cell adhesion molecule, N-cadherin, 
which may be involved in the binding of spermatids to Sertoli cells (Perryman et al. 
1996). On the basis of their in vivo studies, O'Donnell et al (1996) proposed that T is 
essential in preventing the premature desquamation of round spermatids from the 
seminiferous epithelium. Further evidence for the important role played by T in 
spermatogenesis was demonstrated by the administration of T to normal men leading to 
suppression of sperm output: T suppressed FSH and LH, which later lead to a decrease in 
intra-testicular T levels (Matsumoto et al. 1983; Zhengwei et al. 1998).  
  
1.1.7 Cell-cell interactions in the regulation of spermatogenesis 
 
The identification of multiple testicular cell types has initiated studies of cell-cell 
interactions that have continued for the past 100 years. The research in the area has 
recently been increasing. In 1865, Enrico Sertoli described special branched cells in the 
seminiferous tubules of the human testis. Sertoli postulated  “the function of the branched 
cells is linked to the formation of spermatozoa” (reviewed by Skinner 1991). Further 
analysis of the Sertoli cell and its association with the developing germ cells lead to the 
concept that this “nurse cell” is essential for the germ cell and the process of 
spermatogenesis via cell-cell interactions (Parvinen et al. 1982, 1986; reviewed by 
Skinner 1991; Jégou and Shap 1993; Russell and Griswold 1993; Gnessi et al. 1997; 
Mruk and Cheng 2000). The cell-cell interactions include an environmental interaction, 
nutritional interaction and regulatory interaction (reviewed by Skinner 1991). The lack of 
physical contact between Leydig cells and Sertoli cells or germ cells indicates that the 
nutritional and environmental interactions between these cells are not likely. However, all 
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three types of interactions are possible between Sertoli cells and germ cells and are 
crucial in the direct regulation of spermatogenesis.  
 
Several aspects of testis cell biology that are integrally associated with local cellular 
interactions involved proliferation, growth, differentiation, and germ cell movement by 
regulating the turnover of tight junctions, anchoring junctions, and gap junctions during 
the process of germ cell movement throughout spermatogenesis (Mruk and Cheng 2000). 
The cytoarchitectural arrangements between Sertoli cells and the developing germ cells 
provide one of the most sophisticated environmental cell-cell interactions. The Sertoli 
cell is required to maintain the germ cell syncitium that is connected to all cells derived 
from an initial clone of cells. The presence of junctional contacts between Sertoli cells 
and germ cells suggests that these environmental interactions may be needed for cell 
attachment and association. The continuous nature of germ cell development and the 
presence of the cycle of the seminiferous epithelia indicate that environmental 
interactions between Sertoli cells and germ cells are dynamic and require a rapid rate of 
tissue remodelling. The production of plasminogen activator and other protease activities 
of Sertoli cells may be needed in several aspects of tissue remodelling associated with 
translocation of spermatocytes, degradation of junctional complexes, and release of 
mature spermatozoa into lumen of tubule. The function and control of the proteolytic 
activities in remodelling might be also regulated by paracrine local factors secreted by 
Sertoli cells (Mruk and Cheng 2000). 
 
The nutritional interaction between Sertoli cells and germ cells is required due to the 
presence of the blood-testis barrier (Gilula et al. 1976; Bellvé et al. 1977; Christensen et 
al. 1985; Byers et al. 1991). One of the major functions for the Sertoli cell is to transport 
essential components to the spermatogenic cells sequestered in a unique serum-free 
microenvironment. In the adult testis an interaction, a desmosome-gap junction, forms 
between Sertoli cells and germ cells. These gap junctions are mainly required for 
transporting compounds between Sertoli cells and germ cells (Russell et al.1983).  
 
Regulatory interactions occur among all testicular cell types. It has been suggested that 
the local production and action of growth factors are required to regulate male gonadal 
function (reviewed by Bellvé and Zhang 1989). Further investigation of potential 
regulatory interactions between Sertoli cells and germ cells requires the elucidation of the 
paracrine factors involved (Pescovitz et al. 1994). Regulatory interactions between Sertoli 
cells and germ cells were proposed when the concept of paracrine factors and local 
trophic factors was developed. Recent studies have identified numerous secretory 
products for specific testicular cell types. These products range from steroids to secreted 
proteins. Interestingly, most of the secretory products identified appear to be involved 
directly or indirectly in cell-cell interactions. These products include transport/binding 
proteins, proteases, extracellular matrix components, growth factors, and cellular 
metabolites.  
 
1.1.8 Autocrine and paracrine modulators of testicular function 
 
A rapidly increasing number of testicular factors are now being identified that modulate 
spermatogenesis in a paracrine or autocrine fashion (Table 1). The physiological 
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functions of many of the factors remain to be identified. The Sertoli cell is the major 
secretory cell type in the seminiferous epithelium (reviewed by Bardin et al. 1988; Jégou 
and Shap 1993; Russell and Griswold 1993; Gnessi et al. 1997). As such, Sertoli cells 
interact with germ, Leydig, and peritubular myiod cells biochemically via paracrine 
factors produced by Sertoli cells in addition to the physical contacts between these cells. 
Moreover, paracrine factors released by germ cells or peritubular myoid cells can also 
regulate Sertoli cell and testicular functions illustrating the existence of a two-way 
trafficking between these cells (reviewed by Jégou and Shap 1993; Russell and Griswold 
1993; Spiteri and Nieschlag 1993; Pescovitz et al. 1994; Huhtaniemi and Toppari 1998). 
Spermatogenesis defects in men are not improved by gonadotropin, which raises the 
possibility that abnormalities of local paracrine or autocrine factors might be underlying 
the defects. It has been estimated that the abnormalities of the possible local factors may 
contribute to 40-80% of infertility cases in men with oligozoospermia or azoospermia 
(reviewed by Baker et al. 1986; Matsumoto 1991, Escalier 1999). There is accumulating 
evidence that growth factors may function in an autocrine or paracrine fashion to 
stimulate mitosis, growth, angiogenesis, and differentiation in the testis (reviewed by 
Ackland et al. 1992). In vivo, both gene disruption and transgenic mice have showed the 
importance of paracrine or autocrine regulation of growth factors and receptors in 
spermatogenesis. For instance, spermatogenesis abnormalities have been found in BMP-
8a and -8b deficient mice (Zhao et al. 1996, 1998). SCF is expressed by Sertoli cells, the 
c-kit receptor is expressed in germ cell. Mice harbouring mutations at the dominant white 
spotting (W) (Russell 1949) or steel (Sl) (Sarvella and Russell 1956; Reith and Bernstein 
1991) loci exhibit similar pleiotropic abnormalities. Male mice with natural mutations in 
either W or Sl genes encoding for c-kit/SCF are sterile due to the lack of germ cells in the 
testis. Thus, the SCF/c-kit interaction is essential for normal germ cell development 
(reviewed by Russell 1979; Dubreuil et al. 1990; Vincent et al. 1998; Yan et al. 1999; 
2000a,b). Both reduction of circulating epidermal growth factor (EGF) by 
sialoadenectomy and EGF overexpression result in hypospermatogenesis and male 
sterility (Tsutsumi et al. 1986; Liu et al. 1994; Wong et al. 2000). Proper EGF expression 
is thus important for the completion of spermatogenesis. 
 
Table 1. Presumed functions of some paracine/autocrine factors in the testis 
Factor Site Function or presumed function 
ABP 
Transferrin 
Inhibin 
 
Activin 
 
IGF-I 
 
FGF-2 
TGFα 
TGFβ 
MIS 
IL-1 
SC 
SC 
SC, LC 
 
SC, LC 
 
LC, SC 
 
LC, SC, GC,PC 
SC 
SC, LC, PC 
SC 
SC, LC 
Androgen transport and storage 
Iron transport  
Inhibits FSH secretion; Inhibitory autocrine factor. 
Stimulates LC steroidogenesis. 
Stimulates Sg; Stimulatory autocrine factor. 
Inhibits LC steroidogenesis. 
Stimulates LC steroidogenesis, peritubular cell, Sg, 
early Sd; Stimulatory factor. 
Stimulates LC steroidogenesis, pachytene Sp. 
Stimulates PC, LC, GC growth. 
Modulates LC steroidogenesis, inhibits PC growth. 
Stimulates prepubertal GC, Sg, and Sp growth. 
Stimulates PGC, Sg, and Sp growth. 
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IL-6 
SCF 
 
α-MSH 
β-Endorphin 
NGF 
TNF-α 
Polyamines 
 
Estradiol 
 
EGF 
 
BMP-8a, -8b 
PDGF 
SC 
SC 
 
LC 
LC 
GC 
GC 
SC 
 
SC 
 
GC, SC 
 
GC 
SC 
Stimulates GC growth. 
Stimulates PGC development and Sg proliferation 
and survival. 
Stimulates SC proliferation and function. 
Inhibits SC proliferation and function. 
Regulates SC ABP production & other function? 
Modulates SCF function. 
Regulates GC proliferation and differentiation. 
Inhibits FSH binding to receptor. 
Prepubertal stimulatory autocrine factor. Inhibits 
LC steroidogenesis. 
GC survival, regulates T production of LC, affects  
SC. 
GC survival. 
Stimulates adult Leydig cell development 
 
ABP, androgen binding protein; FGF-2, fibroblast growth factor-2; GC, germ cell; LC, 
Leydig cell; IGF, insulin-like growth factor; IL, interleukin; MIS, anti-Müllerian 
hormone; MSH, melanocyte-stimulating hormone; NGF, nerve growth factor; PC, 
peritubular cell; SC, Sertoli cell; Sg, spermatogonia; Sp, spermatocytes; TGF, 
transforming growth factor; TNF, tumour necrosis factor; EGF, epidermal growth factor; 
BMP-8a and -8b, bone morphogenetic protein-8a and -8b; PDGF, platelet-derived growth 
factor.  
 
1.2 Testicular germ cell tumours  
 
1.2.1 Classification of testicular germ cell tumours 
 
Male germ cell tumours (GCTs) comprise about 2% of all human malignancies. Over the 
past several decades, the incidence of GCTs has been steadily increasing in the Western 
world (Toppari et al. 1996; Bergström et al. 1996; Skakkebaek et al. 1987; Skakkebaek et 
al. 1998). Among testicular tumours, GCTs are the most common malignancy in young 
men at the age about 18-50 years (Skakkebaek et al. 1987; Bosl and Motzer 1997). 
Testicular cancer patients are treated with orchiectomy, and the treatment is thereafter 
dependent on histology and stage (Sundström et al. 2001). The majority of testicular 
GCTs (TGCTs) show exquisite sensitivity to cisplatinum-based treatment and irradiation. 
The prognosis of testicular cancer has improved considerably during the past 20 years 
owing to the development of cisplatin-based combination chemotherapy, however the 
mortality rate is still about 10% (Sundström et al. 2001). TGCT can be grouped clinically 
and histologically into two entities, seminoma (SE) (about half the TGCTs), which is 
subgrouped into classic seminoma (CS) and spermatocytic seminoma (SS), and 
nonseminomatous (NSE) GCT (≈40% of the cases). The remaining cases of GCTs 
comprise combined SE- and NSE-GCT components (Skakkebaek et al. 1987; Mostfi et 
al. 1987). NSEs exhibit various patterns of embryonal-like differentiation: primitive 
zygotic embryonal carcinoma (EC), embryonal-like somatically differentiated (teratoma), 
and extra-embryonally differentiated (choriocarcinoma, yolk sac tumour) phenotypes.  
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1.2.2 Carcinoma in situ  
 
The histogenesis of GCTs in humans has been thoroughly investigated since 1972, when 
Skakkebaek reported on atypical spermatogonia in testicular biopsies of two infertile 
patients who later developed testicular cancer. These precancerous germ cells are known 
as carcinomainsitu (CIS) (Skakkebaek 1972; Skakkebaek and Berthelsen 1978). 
Morphologically, CIS consists of atypical, intratubular germ cells that are usually located 
in a single row at the basement membrane of seminiferous tubules. CIS cells are larger in 
diameter than normal spermatogonia; the nucleus is also larger than that of normal 
spermatogonia and usually contains several large nucleoli (Skakkebaek and Berthelsen 
1978; Skakkebaek et al. 1987). The diameter of CIS tubules is usually decreased and the 
basement membrane is thickened. In most cases, the tubules with CIS do not have 
ongoing spermatogenesis and contain Sertoli cells as the only additional cell type 
(reviewed by Rørth et al. 2000). CIS cells probably originate from PGCs early during 
embryogenesis as a consequence of endocrinological imbalances. An excess of estrogens 
during early embryonic life might stimulate PGCs to acquire the tumorigenic potential of 
CIS cells (Skakkebaek et al. 1987, 1998; Dieckmann and Skakkebaek 1999). 
Ultrastructural studies have indicated a close resemblance of CIS cells to embryonal germ 
cells. Furthermore, the CIS cells have histochemical features in common with gonocytes 
(Skakkebaek et al. 1987), both cell types being rich in glycogen and placental alkaline 
phosphatase (PLAP). CIS cells express embryonic antigens (Jørgensen et al. 1993; 
Rajpert-De Meyts et al. 1996a,b). CIS cells have been found in individuals only a few 
months old, which also supports the assumption that these cells are of foetal origin. 
Aneuploid DNA contents of CIS cells were first observed in 1981 (Müller and 
Skakkebaek 1981). As the natural course of CIS is rather predictable, i.e. 50% of cases 
with CIS progress to invasive GCT within five years and in the long-term most, if not all, 
become invasive (Skakkebaek and Berthelsen 1978). Treatment is required to prevent the 
malignant transformation. There are four options for therapy: orchiectomy, cisplatin-
based chemotherapy, low-dose radiotherapy, and temporal surveillance (Dieckmann and 
Skakkebaek 1999). 
 
Probably, CIS remains in a dormant stage and divides at a very slow rate in the early 
years of childhood. Whether or not they give rise to GCT at this early point is unknown. 
After puberty, probably as a consequence of raised sex hormone levels, CIS cells start to 
divide. Several studies have shown that the CIS cells are the common precursor of adult 
and adolescent testicular GCTs for both SEs and NSEs (Skakkebaek and Berthelsen 
1981; Skakkebaek et al. 1984; Skakkebaek and Berthelsen 1987; Dieckmann and 
Skakkebaek 1999). One exception is SS that appears to be a distinct entity that develops 
directly from germ cells (Skakkebaek et al. 1987; Dekker et al. 1992). Evidence for this 
assumption is provided by the lack of PLAP in the cells of this tumour type, the lack of 
CIS cells in the vicinity of these tumours, and different clinical behaviour. The infantile 
testicular tumours may also not be derived from CIS cells because they are not 
accompanied by CIS in the surrounding testicular tissue (Jørgensen et al. 1995). Almost 
all the GCTs which become manifest around the time of puberty and sexual maturations 
are NSE, whereas an increasing proportion of germ cell tumours are SEs with increasing 
age (Skakkebaek et al. 1998). There is more and more evidence that the CIS cell is a 
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malignant gonocyte with stem cell potential (Hanaoka et al. 1991; Matsui et al. 1992; 
Skakkebaek et al. 1998). This explains why an adult man can develop a NSE, which is a 
neoplastic recapitulation of embryonic growth. CIS lesions often develop into SE in one 
part, and NSE in another part of the same testicle. The capacity of CIS cells to develop 
into NSE tumours may decrease with age, as NSEs are rare after the age of 40 
(Skakkebaek et al. 1998). In large patient materials no cases of CIS were found in men 
older than 50 years (Dieckmann and Loy 1996).  
 
It is still unknown whether NSEs develop through a stage of SEs or progress directly 
from CIS to teratoma or embryonal carcinoma. It is unlikely that SE could transform into 
teratoma or embryonal carcinoma. This is suggested by the fact that the transplanted 
JKT-1 and JKT-HM SE cell lines in nude mice only formed SE-type tumours but not 
NSEs (Jo et al. 1999). Moreover, the differential expression of tumour markers might 
indicate that in the histogenesis of NSE there is not necessarily an intermediate stage of 
SE (Looijenga et al 1993; Rajpert-De Meyts et al. 1996b). Most likely, CIS may directly 
progress to either SE or to NSE, probably via intermediate stages of "SE-like CIS" or 
"NSE-like CIS" (Dieckmann and Skakkebaek 1999). Cytogenetic analyses have shown 
that CIS cells alongside SE have higher numbers of copies of chromosome 12 and 15 
than CIS surrounding NSE (Looijenga et al. 1993). CIS cells as well as SE cells usually 
exhibit hypertriploid (triploid-tetraploid) DNA contents (De Jong et al. 1990). 
Immunohistologically, CIS associated with SE has a very high expression of PLAP and 
c-kit and a low expression of TRA-1-60, whereas CIS surrounding NSE has a high 
expression of TRA-1-60 and low or no expression of PLAP and c-kit (Rajpert-De Meyts 
et al. 1996a,b).  
 
1.2.3 Seminomatous germ cell tumours  
 
SE, approximately half of the cases of TGCTs, is a tumour entity with two distinct 
subtypes consisting of CS and SS. The CS is the common type in young men at the age of 
18-50 (reviewed by Rørth et al. 2000). It is composed of fairly uniform medium-sized 
cells with clear cytoplasm and well-defined cell borders, resembling primitive germ cells. 
The cytoplasm is usually rich in glycogen and alkaline phosphotase. A characteristic 
feature of SE is the lymphocytic and granulomatous reaction of the stroma. The cells 
occur in lobules, rows or columns (Mostofi and Bresler 1976; Skakkebaek and Berthelsen 
1978; Mostofi 1980; Skakkebaek et al. 1987). 
 
The origin of CSs remains an enigma. Three hypotheses concerning the histogenesis of 
these tumours have been considered. Firstly, the CIS seems to originate from embryonal 
germ cells, the gonocytes. It may be possible that some germ cells survive in their 
embryonic state into adulthood (See Carcinoma in situ). Secondly, perhaps malignant 
transformation of type A spermatogonia is associated with the dedifferentiation of adult 
germ cells so that they revert structurally and functionally to more primitive precursor 
cells (Holstein et al. 1987). Thirdly, the most likely target cell type for transformation 
during germ cell development may be zygotene-pachytene spermatocytes with replicated 
chromosomes (Chaganti and Houldsworth 2000). The third hypothesis is based on the 
genetic properties of GCTs, i.e. increased 12p copy number, expression of cyclin D2 
(CD2) in CIS, near triploid-tetraploid chromosome numbers, and abundant expression of 
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wild-type p53. CD2 is a chromosome 12p-based candidate gene whose overexpression 
may be induced by aberrant recombination of p53-arrested premeiotic pachytene 
spermatocytes. This gene acts as an oncogene via its ability to induce phosphorylation of 
the retinoblastoma gene product and could be responsible for stimulating the tetraploid 
cells, the arrested meiotic cells, to reinitiate the mitotic cycle (Chaganti and Houldsworth 
2000). 
 
The SS shows not only homogeneous fields or cords of cells, but also large, often 
gigantic cells that are supposed to represent spermatocytes or type B spermatogonia 
without the expression of PLAP, a differentiated spermatogenic cell type (Skakkebaek et 
al. 1987; Looijenga and Oosterhuis et al. 1999, Kraggerud et al. 1999).  
 
1.2.4 Etiology and epidemiology of testicular germ cell tumours 
 
Several predisposing factors for GCTs development have been identified, which include 
cryptorchidism, spermatogenic or testicular dysgenesis, Klinefelter's syndrome, prior 
history of a GCT or contralateral testis with GCT, and a positive family history (reviewed 
by Skakkebaek 1978; Dieckmann and Skakkebaek 1999; Rørth et al. 2000). Although the 
CIS cell is generally regarded as the precursor of adult male GCTs, the target stage of 
germ cell development at which transformation occurs is not known. It was suggested 
that foetal gonocytes have escaped properly timed differentiation (Skakkebaek et al. 
1987), and undergo abnormal cell divisions mediated by a kit receptor/SCF paracrine 
loop leading to the origin of CIS cells (Skakkebaek et al. 1998; Rajpert-De Meyts et al. 
1996b). The CIS cells give rise to both seminomatous and nonseminomatous GCTs (see 
Carcinoma in situ).  
 
Abnormal function or a reduced number of foetal Sertoli cell and Leydig cells may be 
crucial, not only for abnormal preservation of gonocytes postnatally, but also for a 
parallel development of other gonadal abnormalities such as impaired spermatogenesis, 
undescended testis and hypospadias. Undescended testis, a common condition carrying a 
risk of testicular cancer, also seems to be associated with an increased number of 
gonocytes during the early postnatal years (Huff et al. 1993). Boys with cryptorchidism 
often harbour atypical spermatogonia with an aneuploid chromosome component (Müller 
and Skakkebaek 1984). A critical question is, however, which factors determine normal 
as opposed to abnormal differentiation of the gonocytes. In this regard, the Sertoli cells 
and Leydig cells and their products (growth factors and steroids) are interesting 
candidates. In other words, we should focus on the endocrinology and paracrinology 
within the testis.  
 
The gonadal dysgenesis model poses an interesting paradox for the role of Sertoli cells in 
GCTs. On one hand, Sertoli cells in the dysgenetic testis may have been ineffective in 
stimulating the differentiation of the gonocytes into normal spermatogonia in foetal life, 
and are therefore responsible for the persistence of CIS-like cells. On the other hand the 
patients with gonadal dysgenesis often harbour a so-called gonadoblastoma, a tumour 
with low malignancy and invasiveness (Jørgensen et al. 1997). The germ cells of 
gonadoblastoma often have CIS characteristics: not only are they morphologically 
identical, but they also express immunohistochemical markers of CIS and have an 
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aneuploid DNA pattern similar to CIS cells (Jørgensen et al. 1997). Why do they tend to 
be clinically benign? The reason may be related to the lack of mitogenic stimuli from 
Sertoli cell-derived growth factors. The supporting cells of the gonadoblastoma cannot 
really be characterised as normal Sertoli cells.  
 
Recent studies have shown that Leydig cell function may also be impaired in men with 
testicular cancer (Petersen et al. 1998). Androgen insensitivity syndrome is associated 
with a very high risk of germ cell neoplasia (Rørth et al. 2000). Is there an increasing 
trend of abnormalities of the male reproductive system including testicular cancer linked 
to increasing levels of estrogens during pregnancy? This question was recently posed by 
researchers interested in estrogen hypothesis, which implicates the so-called 
environmental estrogen as a possible cause for the increasing frequency of male 
reproductive abnormalities (reviewed by Toppari et al. 1996). Several studies suggested 
that some of the reproductive abnormalities to which testicular cancer is 
epidemiologically linked can be caused by exposure to increased levels of estrogen in 
utero. A high estrogen level in the pregnant woman could be a risk factor for 
development of testicular cancer in her son (Depue et al. 1983). Some evidence came 
from the investigation of offspring of mothers who were taking the potent estrogen 
diethylstilboestrol during pregnancy (Dieckmann et al. 1953). It was also demonstrated in 
a mouse model that intrauterine exposure to diethylstilboestrol could induce poor semen 
quality, cyptorchidism, and testicular cancer. However this model does not show the 
pathological characteristics of human SE and NSE (McLachlan et al. 1975; Newbold and 
Bunge 1987; Looijenga and Oosterhuis 1999). It is now clear that this is not the whole 
story. Late foetal life, postnatal, pubertal and post-pubertal endocrinological factors also 
seem to play a role (Toppari et al. 1996; Skakkebaek et al. 1998). Epidemiological 
evidence suggests that environmental factors are involved in the steadily increasing 
incidence of testicular cancer (Brown et al. 1987; Adami et al. 1994; Toppari et al. 1996; 
Skakkebaek et al. 1998). Many environmental pollutants have estrogenic or anti-
estrogenic activity leading to the hypothesis that hormonal disruption may be causing the 
increased incidence of testicular cancer and genital abnormalities (reviewed by Toppari et 
al. 1996; Skakkebaek et al. 1998). Geographical differences in the incidence of testis 
cancer suggest that there are probably many confounding factors, including genetic 
susceptibility and lifestyle factors, such as diet.  
  
One major reason for the poor understanding of the biology of GCTs is the lack of animal 
models and established cell lines. The establishment of a TGCT cell line or animal model 
may provide a powerful tool for studying the pathogenesis and novel treatment of TGCT. 
The first GCT cell line was established through the culture of EC cells (Fogh and Trempe 
1975). Since then, various other NSE-TGCT cell lines have been established, and due to 
the stem cell features of these cells they can contribute to germ layers in the chimeric 
mice (Hanaoka et al. 1991). However, the establishment of SE cell lines can be very 
difficult because they cannot be cultured in vitro for a prolonged period (Berends et al. 
1991; Olie et al. 1995). In 1995, Olie et al. were only able to initiate proliferation of SE 
cells and enhance the survival of the cell lines to a maximum of 30 days. In 1998, 
Tanaka’s research group established the first SE cell line JKT-1, which has been cultured 
for more than two years and shows metastases when these cells are grafted to nude mice 
(Kinugawa et al. 1998). In 1999, this group isolated a new metastatic SE cell line JKT-
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HM by transplanting cells from the cell line JKT-1 into the dorsal skin of nude mice. The 
transplanted cell line only forms SEs and the tumours are metastatic. JKT-HM displays 
the typical triploid karyotype of SE (Jo et al. 1999). Progress in this field of research has 
been hampered by the fact that no animal model has yet been established which mirrors 
testicular germ cell cancer in human. 
 
1.2.5 Testicular tumours in animals 
 
Spontaneous GCTs of the testis are extremely rare in rodents and other animals. Two 
cases of teratoma and EC in 8- and 10- week-old Sprague-Dawley IGS rats have recently 
been reported (Sawaki et al. 2000). Only a few cases of SE in animals have been 
published (Mitsumori et al. 1988; Veeramachaneni et al. 1999; Peters et al. 2000a,b, 
2001). All the reported SE cases are invariably likely to be SS. The most common type of 
testis tumour in animals is of Leydig cell origin. The Leydig cell is a common target of 
compounds tested in rodent carcinogenicity bioassays (Cook et al. 1999). Although 
testicular tumours are inducible by endocrine disrupting chemicals (EDCs) such as 
diethylstilbestrol, most of the tumours are interstitial cell tumours, but not germ cell 
tumours (Imaida and Shirai 2000). Leydig cell and Sertoli cell tumours have also been 
studied in dogs (Peter et al. 2000a,b, 2001). In dogs with a SE, hormone concentrations 
were not different from those of normal dogs (Peters et al. 2000b). Dogs with a Sertoli 
cell or Leydig cell tumour had higher estradiol concentration and inhibin-like 
immunoreactivity in both peripheral and testicular venous circulation. Therefore it was 
concluded that SEs are not endocrinologically active (Peters et al. 2000b).  
 
A possible murine model for human GCTs was identified early (Stevens and Little 1954; 
Stevens 1967): spontaneous testicular teratomas develop in the inbred mouse strain 
129/Sv. In addition, testicular teratoma developed when genital ridges from day 12-13 
embryos were transplanted into adult testis (Stevens 1970). These tumours have been 
studied extensively over the past four decades. They have been shown to be derived from 
PGCs, they comprise of apparently normal and mutated genomes, they are transplantable 
and able to participate in normal murine development (Matin et al. 1998). The human and 
this murine GCTs share certain features reflecting their germ cell origin, i.e. 
pluripotentiality, expression of wild type p53, and sensitivity to DNA-damaging agents 
(Matin et al. 1998; Lutzker and Levine 1996). These features have made them a 
potentially attractive model system for the analysis of carcinogenesis. Recent studies 
have shown that mutations at certain gene loci, such as Ter and Trp53, significantly 
enhance the susceptibility of the 129/Sv strain to develop teratomas (Asada et al. 1994; 
Donehower 1996). More recently, a 129 strain locus, a male germ cell tumour-
susceptibility-determining locus pgct1 has been identified on chromosome 13 near 
D13Mit 188 (Muller et al. 2000). In contrast, adult human male GCTs arise from pre-
existing CIS, their genomes are heteroploid and aberrant, and, as discussed above, no 
predisposing genetic factors have been identified as yet. Therefore, murine teratomas do 
not appear to be good models for adult male GCTs in terms of their ontogenesis. 
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1.3 GDNF family and receptors 
 
1.3.1 Introduction to GDNF family and receptors 
 
Glial cell line-derived neurotrophic factor (GDNF) family of neurotrophic factors 
consists of small secreted molecules that are responsible for many functions in the 
development, differentiation and survival of mainly neural but also other tissues 
(reviewed by Airaksinen et al. 1999; Saarma and Sariola 1999; Baloh et al. 2000). The 
first member of the GDNF family was identified due to the ability of the conditioned 
media of a glial cell line culture to promote the survival of dopaminergic neurones. 
GDNF was purified and cloned by this neuronal survival approach which is a classic way 
to search for secreted neurotrophic factors. The characterisation of GDNF rendered it to a 
distant member of the transforming growth factor β (TGFβ) family (Lin et al. 1993). New 
members of the GDNF family including neurturin (NRTN), persephin (PSPN) and 
Artemin (ARTN) were characterised thereafter (Kotzbauer et al. 1996; Baloh et al. 1998; 
Milbrandt et al. 1998). All these factors are structurally closely related sharing about 40% 
identity at amino acid level. They also share the sequence suggesting a common “cysteine 
knot” formed by three disulfide-bonds. Due to their function as disulfide-bonded 
homodimers and sharing of the conserved cysteine residues of TGFβ superfamily, they 
were classified as a subfamily of TGFβ superfamily, although the overall amino acid 
homology for instance to TGFβ-1 is not more than 20% (Milbrandt et al. 1998). Similar 
to neurotrophins, the GDNF family ligands are also first synthesised as precursor 
polypeptides that are processed to mature proteins and secreted (Lin et al. 1993) (Fig. 5). 
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Figure 5. Schematic structure of the prepropeptides of GDNF family members. The 
number of amino acids of the pre- and proregions, and of mature proteins and the 
positions of the seven conserved cysteine residues (white lines) are shown. According to 
Airaksinen et al. 1999. 
 
The potential receptor binding surfaces have been identified based on the X-ray crystal 
structure of GDNF (Eigenbrot and Gerber 1997). GDNF family members mediate their 
biological functions via a multicomponent receptor complex (see Fig. 6), which includes 
a signal transducing receptor, the Ret receptor tyrosine kinase, and 
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glycosylphosphatidylinositol (GPI)-linked cell surface coreceptors, GDNF family 
receptor alphas (GFRαs) (reviewed by Airaksinen et al. 1999; Saarma and Sariola 1999; 
Baloh et al. 2000; Takahashi 2001). The high affinity of GDNF binding to Ret is 
mediated through a GFRα receptor (originally named GDNF receptor-α) (Jing et al. 
1996; Treanor et al. 1996). The primary specificity of the coreceptors for GDNF, NRTN, 
ARTN and PSPN is GFRα1, GFRα2, GFRα3, and GFRα4, respectively (reviewed by 
Airaksinen et al. 1999; Saarma and Sariola 1999; Baloh et al. 2000). However, a weak 
cross-talk between ligands (GDNF, NRTN, ARTN) and coreceptors (GFRα1, GFRα2, 
GFRα3) has been observed in vitro (Baloh et al. 1997; Jing et al. 1997; reviewed by 
Saarma 2000), except that mammalian GFRα4 receptor binds only PSPN (Lindahl et al. 
2001). The downstream signalling pathways are thought to be mostly common for all 
GDNF family members since all GFRαs bind to and activate the same tyrosine kinase. 
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Figure 6. The binding of GDNF family ligands and receptors. The solid arrows 
represent the functional binding that activates Ret most potently, whereas the dotted 
arrows indicate weak interactions with receptor that may not be physiologically 
significant in vivo. 
 
1.3.2 GDNF 
 
Transcription of the GDNF gene usually produces a full-length GDNF mRNA of 4.5 kb, 
but a 6.0 kb transcript mRNA species has also been observed. The coding region of 
GDNF gene is 633 bp, which encodes a 211 amino acid precursor polypeptide, from 
which the mature protein of 134 amino acid is produced by proteolytic cleavage (Lin et 
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al. 1993). There are two potential glycosylation sites in the mature protein, which has a 
Mr of 18 to 22 kDa (Lin et al. 1993). An alternatively spliced GDNF mRNA lacking 78 
bp in the preproregion has been found, but since it gives rise to the same mature GDNF, 
the function of the different splicing is unknown (Suter-Crazzolara and Unsicker 1994). 
 
GDNF promotes the survival of several types of neurones in both the central and 
peripheral nervous systems. Exogenous GDNF can maintain dopaminergic, noradrenergic 
and motor neurones of the central nervous system (Lin et al. 1993; Henderson et al. 1994; 
Arenas et al. 1995; Oppenheim et al. 1995; Tomac et al. 1995; Yan et al. 1995; Gash et 
al. 1996; Messer et al. 2000; Rosenblad et al. 2000), as well as various sub-populations of 
the peripheral sensory and sympathetic neurones (Henderson et al. 1994; Buj-Bello et al. 
1995; Ebendal et al. 1995; Trupp et al. 1995; Arce et al. 1998). The pharmacological 
effects of GDNF on midbrain dopaminergic neurones have been studied on several 
animal models in both rodents and non-human primates (reviewed by Lapchak et al. 
1997; Grondin et al. 1998). Therefore, GDNF is considered a potential drug candidate for 
the treatment of Parkinson's disease. The in vivo functions of GDNF in the central and 
peripheral nervous systems have been studied by the in vivo loss-of-function and gain-of-
function of GDNF in transgenic models, (Moore et al. 1996; Pichel et al. 1996; Sánchez 
et al. 1996; Nguyen et al. 1998). The development of the dopaminergic neurones in 
GDNF-deficient embryos is normal. However the homozygous mice die at birth before 
the maturation of dopaminergic nervous system. The GDNF-deficient mice show a 20%-
30% reduction in the number of motoneurones in trigeminal ganglia and the spinal cord 
(Moore et al. 1996; Sánchez et al. 1996). The transgenic mice overexpressing GDNF 
under a muscle-specific myogenin promoter show hyperinnervation of neuromuscular 
junctions for several weeks after birth (Nguyen et al. 1998), suggesting that GDNF also 
functions as a muscle-derived factor for motor axon branching and synapse elimination. 
The studies of GDNF-/-, GFRα1-/-, and Ret-/- mice revealed that these mutant mice had 
a remarkably similar phenotype. These mutant mice fail to develop kidneys and to 
innervate the gastrointestinal tract below the stomach (Schuchardt et al. 1994, 1996; 
Moore et al. 1996; Pichel et al. 1996; Sánchez et al. 1996; Cacalano et al. 1998; Enomoto 
et al. 1998). Subsequent analyses of the enteric nervous system in these mice establish 
that GDNF is crucial for the early development of the enteric nervous system (Taraviras 
et al. 1999). A loss of certain cranial parasympathetic ganglia (otic and sphenopalatine) of 
the newborn Ret-, GFRα1-, and GDNF-mutants has been observed indicating that GDNF 
has a similar role in the early development of the parasympathetic nervous system 
(Marcos and Pachnis 1996; Enomoto et al. 2000; Rossi et al. 2000). 
 
Outside the nervous system, GDNF mRNA is abundantly expressed in the condensating 
nephrogenic mesenchyme cells around the tips of the invading ureteric buds while 
branching bud tips express the functional receptor Ret (Pachnis et al. 1993; Hellmich et 
al. 1996; Suvanto et al. 1996; Widenfalk et al. 1997, 2000). The development of the 
metanephric kidney is initiated by the reciprocal interaction of nephrogenic mesenchyme 
and the Wolffian duct-derived ureteric bud (Saxén 1987). This inductive interaction of 
the mesenchyme and ureteric epithelium can be mediated by growth factors and their 
receptors (Saxén 1987; Sariola and Sainio 1997; Sariola and Saarma 1999). The special 
expression pattern of GDNF and Ret suggested a crucial paracrine regulatory role of 
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GDNF in kidney morphogenesis. In vitro culture studies and gene disruption studies 
clarified that GDNF, a mesenchyme-derived signal, is crucial in the regulation of ureteric 
bud epithelia in branching morphogenesis (Durbec et al. 1996a; Sainio et al. 1997; 
Pepicelli et al. 1997). GDNF-deficient mice lack kidneys and die in the first postnatal day 
(Moore et al. 1996; Pichel et al. 1996; Sánchez et al. 1996). GDNF haploinsufficiency in 
heterozygotes (GDNF+/-) of these mice often exhibits unilateral renal agenesis or rarely 
dysgenesis (Moore et al. 1996; Pichel et al. 1996; Sánchez et al. 1996). In vitro, early 
ureteric buds will grow toward localised sources of GDNF (Durbec et al. 1996a; Pepicelli 
et al. 1997; Sainio et al. 1997). GDNF increases cell mobility, dissociation of cell 
adhesion, and migration of Ret-transfected Madin-Darby canine kidney (MDCK) cell line 
toward a localised source of GDNF (Tang et al. 1998). Disruption of GDNF function 
with neutralising antibodies also showed that GDNF is necessary for the development of 
the ureteric bud (Vega et al. 1996). Addition of soluble GDNF to organ culture results in 
an increased number of ureteric tips (Vega et al. 1996, Pepicelli et al. 1997). The 
inductive signals may be mediated by GDNF through its receptor without the close 
interaction of mesenchyme and epithelia. It has been recently shown that GDNF, 
combined with mesenchyme-derived soluble factors, also induces branching 
morphogenesis of ureteric buds in the absence of mesenchymal tissue (Qiao et al. 1999). 
One candidate for the unknown metanephric mesenchymal derived soluble factor(s) was 
recently identified as pleiotrophin (Sakurai et al. 2001). It has also been proposed that an 
unknown stromal signal is induced by retinoic acid (Vitamin A), which then induces Ret 
expression in the ureteric bud (Batourina 2001). 
 
During development, GDNF is abundantly expressed in a number of tissues where the 
possible role of GDNF is still unclear. For instance, GDNF is expressed in the 
mesenchyme of the developing limb, in the tip of the embryonic tongue, cartilage and 
derivatives of the pharyngeal pouches (Hellmich et al. 1996; Suvanto et al. 1996; Golden 
et al. 1999). GDNF is also expressed in the testis and probably by Sertoli cells (Hellmich 
et al. 1996; Suvanto et al. 1996; Golden et al. 1999; Viglietto et al. 2000; Widenfalk et al. 
2000). GDNF is able to stimulate mitosis of cultured germ cells isolated from prepuberal 
mice (Viglietto et al. 2000), and in postnatal rat testes, GDNF was demonstrated to 
enhance FSH-induced Sertoli cell and gonocyte proliferation (Hu et al. 1999). 
 
1.3.3 NRTN 
 
NRTN, with 42% similarity to GDNF at amino acid level, was identified on the basis of 
its ability to support the survival of sympathetic postganglionic neurones in culture 
(Kotzbauer et al. 1996). Similar to GDNF, NRTN is first synthesised as a precursor 
polypeptide, then processed to mature protein, and secreted (Fig. 5). The mature NRTN 
has a predicted Mr of 11.5 kDa (Kotzbauer et al. 1996).  
 
NRTN promotes the survival of several populations of neurones in both the central and 
peripheral nervous systems (Klein et al. 1997). Like GDNF, NRTN also has a survival- 
promoting effect on dopaminergic neurones in vitro (Horger et al. 1998). In vivo, NRTN 
has been shown to exert neuroprotective effects in the 6-hydroxydopamine (6-OHDA) 
lesion model (Horher et al. 1998; Rosenblad et al. 1999a,b). There is a difference 
between the effect of GDNF and NRTN on developing and adult substantia nigra 
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dopaminergic neurones; GDNF has wider survival, neuritogenic and hypertrophic effects 
as compared to the selective survival-promoting effects of NRTN (Åkerud et al. 1999; 
Rosenblad et al. 1999a,b). NRTN affects parasympathetic neuronal survival and target 
innervation. NRTN-deficient mice have a strikingly similar phenotype with the mice 
lacking GFRα2 showing defects in the parasympathetic enteric nervous system 
(Heuckeroth et al. 1999; Rossi et al. 1999). They are viable and fertile, but have a 
dramatically reduced parasympathetic cholinergic innervation of the lacrimal and salivary 
glands, and a reduced myenteric plexus innervation. NRTN and GFRα2 together with Ret 
regulate the parasympathetic innervation of the penis and may also have a role in the 
regulation of heart innervation (Laurikainen et al. 2000; Hiltunen et al. 2000). 
 
During embryogenesis the mRNAs for Ret, GFRα1, and GFRα2 are colocalised in 
cranial parasympathetic ganglia (Golden et al. 1999; Enomoto et al. 2000; Rossi et al. 
2000). Embryonic submandibular ganglia neurones respond to NRTN and GDNF, even in 
the absence of GFRα1 suggesting some cross-talk between GDNF and GFRα2 (Cacalano 
et al. 1998). GDNF and NRTN have distinct roles in the regulation of cranial 
parasympathetic ganglia in vivo. GDNF signalling via GFRα1/Ret is essential for 
gangliogenesis of some cranial parasympathetic neurones, whereas subsequent NTRN 
signalling through GFRα2/Ret is crucial for the development and maintenance of 
parasympathetic target innervation (Rossi et al. 2000).  
 
NRTN is widely expressed in other non-neuronal cells and tissues (Widenfalk et al. 1997; 
Golden et al. 1999), where its role remains unclear. In the embryonic kidney, NRTN is 
expressed in both the mesenchyme and developing bud epithelium where it colocalises 
with Ret (Widenfalk et al. 1997). The expression patterns of NRTN and Ret therefore 
suggests a local autocrine regulation in epithelial development of the ureteric bud. NRTN 
is capable of promoting ureteric bud branching (Davies et al. 1999). However, NRTN-
deficient mice do not show any defects in kidney morphogenesis, suggesting either that 
NRTN might be unimportant for kidney development or a possible functional 
redundancy. Although both NRTN and GFRα2 are highly expressed in the testis 
(Widenfalk et al. 1997, 2000; Golden et al. 1999; Viglietto et al. 2000) and both GDNF 
and NRTN were able to stimulate mitosis of cultured germ cells isolated from prepuberal 
mice (Viglietto et al. 2000), no testis phenotype has yet been reported from both NRTN- 
and GFRα2-deficient mice. 
 
1.3.4 Ret receptor tyrosine kinase 
 
1.3.4.1 Ret is a functional receptor for GDNF family ligands 
 
The Ret (rearranged during transfection) proto-oncogene was first identified by 
Takahashi and co-workers who found a novel gene rearrangement and oncogenic activity 
in transfected NIH 3T3 cell line. The gene encodes a novel tyrosine kinase that has an 
extracellular ligand binding domain with four cadherin-like repeats and a cysteine-rich 
domain, a hydrophobic transmembrane region and a cytoplasmic domain with an intrinsic 
tyrosine kinase activity (Takahashi et al. 1985; Takahashi and Cooper 1987; Anders et al. 
2001). In the extracellular domain the cysteines are probably involved in the formation of 
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disulfide bonds, allowing the acquisition of the correct secondary structure (Ponder 
1999). Three isoforms of Ret are generated by alternative splicing at the 3’ end of the 
gene. The long, intermediate, and short Ret isoforms which differ by 51, 43, and 9 amino 
acids in the C-terminus are referred to as Ret51, Ret43, and Ret9. Two major isforms 
Ret51 and Ret9 have different signalling properties in vivo (de Graaff et al. 2001).  The 
extracellular portion of the molecule contains several glycosylation sites. Western blot 
analysis shows two Ret isoforms of Mr 150 kDa and 170 kDa that are glycosylated 
differently (reviewed by Ponder 1999). The Mr 170 kDa isoform is the fully mature 
version of the receptor and is present on the cell membrane. The Mr 150 kDa isoform is a 
maturation intermediate that is present only in the endoplasmic reticulum (reviewed by 
Ponder 1999). 
 
The ligand for the orphan receptor Ret remained unknown for years until it was 
discovered by several groups that the Ret tyrosine kinase is the functional receptor for 
GDNF (Durbec et al. 1996a; Trupp et al. 1996; Jing et al. 1996; Treanor et al. 1996). 
Thereafter, Ret was also shown to be the functional receptor for other members of the 
GDNF family (reviewed by Airaksinen et al. 1999; Saarma and Sariola 1999; Baloh et al. 
2000; Saarma 2000). Ret is expressed in several tissues overlapping with or adjacent to 
sites of GDNF family ligands. During embryonic development, the Ret gene is highly 
expressed in parts of the central nervous system, in the neural crest and many of its 
derivatives, including the peripheral nervous system and neuroendocrine cells, such as the 
C-cells of the thyroid and chromaffin cells of the adrenal gland (Pachnis et al. 1993; 
Takahashi et al. 1993; Tsuzuki et al. 1995; Watanabe et al. 1997). In vivo data from gene 
knockout studies give further evidence for the interaction of GDNF and Ret, because 
GDNF and Ret null mice show a strikingly similar phenotype. The homozygous mice die 
during 24 hours after birth due to renal aplasia or hypoplasia, and lack of enteric 
innervation (Schuchardt et al. 1994, 1996). The discrepancy of some phenotypes between 
Ret and GDNF null mice, for instance the less severe loss of superior cervical ganglia in 
GDNF null mice, may be due to the functional compensation of GDNF by other factors.  
 
Histoarchitecture of the mature kidney is determined largely by the pattern of growth and 
branching of the ureteric bud (Saxén 1987). In the developing kidney the striking parallel 
expression of Ret and GDNF has been observed (Pachnis et al. 1993; Tsuzuki et al. 1995; 
Suvanto et al. 1996; Sariola and Sainio 1997). The restricted expression of Ret and 
GDNF might be important in regulating the extent, and possibly pattern, of ureteric bud 
growth and branching (Sariola and Sainio 1997, Sariola and Saarma 1999; Srinivas et al. 
1999). The misexpression of Ret throughout the ureteric bud branches under the Hox7 
promoter, in contrast to the normal expression only at the bud tip, causes variable 
inhibition of ureteric bud growth and branching reminiscent of, but less severe than, the 
Ret-deficient phenotype (Srinivas et al. 1999). Moreover, expression of a Hox7/Ret-
PCT2 transgene, encoding a ligand-independent form of Ret kinase, also causes the 
development of abnormal nodules, outside the kidney or at its periphery, containing 
branched epithelial tubules apparently formed by deregulated growth of the ureteric bud. 
This suggested that Ret signalling is not only necessary but also is sufficient to induce 
ureteric bud growth, and that the orderly, centripetal growth of the bud tips is controlled 
by the spatially and temporally regulated expression of GDNF and Ret (Srinivas et al. 
1999). 
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1.3.4.2 Ret gene in cancer and Hirschsprung's disease 
 
After the Ret proto-oncogene was discovered, various oncogenic mutations and 
translocations of the proto-oncogene were soon found. Gain-of-function and loss-of-
function mutations in the Ret gene lead to cancer syndromes or Hirschsprung's disease 
(HSCR), respectively. Ret induces cell transformation when translocated (Takahashi et al. 
1985). Such gene translocations have been found in human papillary thyroid carcinoma 
(PTC) (Grieco et al. 1990), where the tyrosine kinase domain of the Ret gene is fused 
with the 5’ sequence of a gene that is expressed in follicular cells leading to ectopic Ret 
activation. Activating Ret mutations have been described in the multiple endocrine 
neoplasia type 2 (MEN 2) hereditary cancer syndromes (reviewed by Eng 1999; Ponder 
1999; Takahashi 2001). MEN 2 are dominantly inherited syndromes that comprise of 
three clinical subtypes: MEN 2A, MEN 2B, and familial medullary thyroid carcinoma 
(FMTC). All three include the C-cell tumours, medullary thyroid carcinomas (MTCs), 
which are more aggressive in patient with MEN2B than those seen in patients with 
FMTC or MEN 2A. MEN 2A is characterised by the association with MTC, 
pheochromocytomas, and hyperparathyroidism, while MEN 2B includes MTC, 
pheochromocytomas, neuromas of the lips, tongue and conjunctivae, intestinal 
ganglioneuromatosis, marfanoid skeletal abnormalities and a male reproductive defect 
due to erectile dysfunction with a neurological basis (reviewed by Pasini et al. 1996; Eng 
1999; Ponder 1999). In FMTC, the MTC is the sole clinical manifestation and develops 
late in life (reviewed by Eng 1999; Ponder 1999). All affected patients in MEN 2A and 
2B develop MTC in childhood or as teenagers. In sporadic MTC, tumours are usually 
single and unilateral. In patients with MEN 2A, MEN 2B, and FMTC, the tumour occurs 
as a multifocal, bilateral disease.  
 
The majority of the MEN 2A and FMTC mutations are located in the extracellular 
domain. Missense mutations at one of five cysteines clustered in the extra-cytoplasmic 
domain of Ret (Cys 609, 611, 618, 620, and 634) have been identified in the majority of 
MEN 2A families and in approximately two-thirds of FMTCs (reviewed by Edery et al. 
1997; Eng 1999; Blume-Jensen and Hunter 2001; Manié et al. 2001). These alterations 
result in the substitution of a single cysteine by a different amino acid causing 
constitutive signalling of the tyrosine kinase through the formation of disulfide-linked Ret 
homodimers (reviewed by Ponder 1999; Takahashi 2001). The great majority of MEN 2A 
mutations affect codon 634, while in FMTC the mutations are equally distributed among 
codons 618, 620, and 634. Approximately 95% of MEN 2B cases as well as most cases of 
spontaneous MTC, result from a substitution of threonine for methionine at codon 918 
within the catalytic core of the Ret kinase domain. This replacement increases the kinase 
activity of Ret without constitutive dimer formation, most likely because it enables 
substrate access without prior autophosphorylation of the active loop (reviewed by 
Ponder 1999; Takahashi 2001). In addition, the Ret mutation in MEN 2B alters the 
substrate specificity of the Ret/MEN 2B receptor towards peptide substrates that are 
optimal for Src and Abl. The altered substrate specificity of Ret MEN 2B may contribute 
to the aggressiveness of MEN 2B in vivo (reviewed by Blume-Jensen and Hunter 2001). 
There is a significant increase in phosphorylation after the GDNF stimulation of the 
mutant Ret-MEN 2B in vitro (Bongarzone et al. 1998). The resulting combined 
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oncogenic activation is certainly stronger than that provided by the Cys-634 mutation. 
The long Ret isoform with the MEN 2B mutation is approximately two-fold more 
transforming in vitro than the same Ret isoform with a MEN 2A mutation (Cys 634 to 
Arg). This could be an additional explanation for the earlier onset of tumours in MEN 2B 
(Iwashita et al. 1996).  
 
In all these hereditary or sporadic malignant diseases, Ret is constitutively 
phosphorylated due to missense mutations either in the extracellular domain, critical for 
the receptor dimerisation, or in the intracellular catalytic domains of the tyrosine kinase. 
Interestingly, the tumours in the MEN 2 develop in only a few organs, although Ret is 
expressed in many tissues, suggesting modulatory mechanisms, which are supposed to be 
mediated by the different GFRα receptors (Kawai et al. 2000, Lindahl et al. 2001). 
Recently, receptors Ret, GFRα1 and 2, and ligands (GDNF and NRTN) were found in 
seminoma cells (Viglietto et al. 2000), but it is not clear yet if Ret is mutated or 
hyperphosphorylated in seminoma or has a role in its pathogenesis.  
 
In humans, heterozygous loss-of-function mutations in Ret lead to absence of enteric 
ganglia from the distal colon and congenital megacolon (HSCR; Parisi and Kapure 2000). 
These mutations vary from missense or nonsense point mutations to deletions. They 
result in the inactivation of the tyrosine kinase or ligand binding domain or in the 
perturbance of the membrane transport of the receptor (reviewed by Iwashita et al. 2001, 
Manié et al. 2001, Takahashi 2001). In contrast, inactivation of Ret in mice causes severe 
intestinal agangliosis (Schuchardt et al. 1994, 1996; Durbec et al. 1996b). NRTN and 
GDNF promote proliferation, survival and differentiation of enteric neurones and glial 
progenitors in vitro, GDNF also promotes the migration of enteric crest cells which is 
believed to be an important cause in HSCR (Heuckroth et al. 1998; Worley et al. 2000; 
Taraviras 1999; Young 2001). Though some of the cellular processes controlled by Ret 
(such as survival, migration, and differentiation of enteric neuron cells) have been 
identified in animal models, the mechanisms that lead to the localised absence of enteric 
ganglia in HSCR patients remain unclear. 
 
1.3.4.3 Oncogenic Ret mutations in transgenic mice models 
 
The Ret/PTC oncogene, a rearranged form of the Ret proto-oncogene, has been found in 
human PTCs. Transgenic mouse models with PTCs have been generated by several 
research groups (Jhiang et al. 1996, 1998; Santoro et al. 1996; Portella et al. 1996; 
Sagartz et al. 1997; Powell et al. 1998; Cho et al. 1999). Transgenic mice with thyroid-
specific expression of the Ret/PTC1 oncogene develop thyroid carcinomas with 
considerable similarities to human PTCs, particularly in the nuclear cytological features 
and the presence of local invasion (Jhiang et al. 1996; Santoro et al. 1996). The thyroid 
tumours in these Ret/PTC1 transgenic mice are characterised by a slow growth rate, 
thyroid-stimulating hormone-responsive tumour progression, and loss of radioiodide-
concentrating activity despite continued expression of thyroglobulin (Sagartz et al. 1997; 
Jhiang et al. 1998). The time of the tumour onset appears to be dependent on the 
expression levels of Ret/PTC1 in the transgenic mice (Jhiang et al. 1998; Cho et al. 
1999). The tumours induced by Ret/PTC3 are more aggressive than tumours induced by 
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Ret/PTC1, and metastatic solid-type papillary carcinomas are formed (Powell et al. 
1998). Interestingly, the ubiquitous expression of Ret/PTC1 in transgenic mice carrying 
the Ret/PTC1 under the H4 promoter only develop mammary and cutaneous gland 
tumours, suggesting that Ret/PTC1 is able to couple with transforming pathways specific 
for these glandular cells (Portella et al. 1996). 
 
All MEN 2 mutations tested so far convert the Ret proto-oncogene into a dominantly 
acting transforming gene, as the wild-type Ret allele is usually retained and expressed in 
tumour tissue (Tsuzuki et al. 1995). Ret-MEN 2A and Ret-MEN 2B mutations are 
oncogenic in the fibroblast transformation assay (Rossel et al. 1997). Their biological 
effects in thyroid C-cells and adrenal chromaffin cells have remained elusive. It was not 
clear whether these mutations interfered with one or more normal developmental 
functions of Ret. Therefore, transgenic models have been created to solve these questions.  
 
The most common mutation in MEN 2A (52% of all cases) occurs at codon 634 and 
results in substitution of Cys-634 for an Arg (TGC→CGC). To examine whether 
expression of a MEN 2A allele of Ret results in transformation of C cells, transgenic mice 
have been constructed in which an active MEN 2A-Ret cDNA is expressed under a 
calcitonin/calcitonin gene-related peptide promoter, giving strong expression in thyroid C 
cells. The mice develop bilateral multiple foci of MTC, similar to the condition seen in 
the thyroid medulla of human carriers of a MEN 2A mutation (Michiels et al. 1997). 
However, the ectopic expression of the 634Arg-Ret transgene in several other tissues, 
such as in the kidney and brain which are not affected in the human MEN 2A, did not 
cause any histological abnormalities suggesting tissue-specific control of carcinogenesis. 
The tissue-specific carcinogenesis was also observed recently in transgenic mice 
ubiquitously expressing the MEN 2A-Ret oncogene fused to Moloney murine leukaemia 
virus long terminal repeats (Kawai et al. 2000). Expression of the transgene was detected 
at variable levels in a variety of tissues including the thyroid, heart, liver, colon, parotid 
gland, testis and brain. All mice developed thyroid C-cell hyperplasia or medullary 
carcinoma, accompanying high levels of serum calcitonin. In addition, the development 
of mammary or parotid gland adenocarcinoma was observed in half of the mice. Ret 
dimerisation and complex formation with Shc and grb2 adaptor proteins were detected in 
tumour tissues. Unexpectedly, no tumour formation was found in other tissues and 
receptor dimerisation was undetectable, although Ret-MEN2A expression was detected.  
 
Most cases of MEN 2B are caused by substitution of Thr for Met918 in the Ret receptor 
tyrosine kinase. When the MEN 2B mutant Ret gene was introduced into the thyroid C 
cells, the transgenic mice developed MTC (Acton et al. 2000). The expression of MEN2B 
in various tissues, including the brain, lung, and kidney, did not induce tumours or 
developmental abnormalities. Transgenic mice were created using the dopamine β-
hydroxylase (DβH) promoter to direct expression of MEN 2B-Ret to the developing 
sympathetic and enteric nervous systems and adrenal medulla. In DβH-MEN 2B-Ret 
mice, MEN 2B-Ret expression did not affect terminal innervation or induce intestinal 
ganglioneuromas or pheochromocytomas (Sweetser et al. 1999). Only sympathetic 
ganglioneuromas and renal anomalies are induced in these transgenic mice, and the renal 
abnormalities may due to the hyperplasia of sympathoadrenal ganglia that could compete 
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for GDNF binding with the ureteric bud (Sweetser et al. 1999; Gestblom et al. 2000). 
Recently, a new MEN 2B-Ret mouse strain has been generated by introduction of the 
corresponding mutation (Ret-Met919Thr) into the Ret locus using gene-targeting 
techniques in conjunction with Cre/loxP site-specific recombination (Smith-Hicks et al. 
2000). Mutant mice displayed C-cell and chromaffin cell hyperplasia, the latter 
progressing to pheochromocytoma. Homozygotes did not develop gastrointestinal 
ganglioneuromas, but displayed ganglioneuromas of the adrenal medulla, enlargement of 
the associated sympathetic ganglia and male infertility. Surprisingly, homozygotes did 
not display any developmental defects attributable to a loss-of-function mutation. Thus, 
the results support the conclusion that the Met918 substitution is responsible for MEN 2B 
and that the altered substrate specificity of the mutant Ret kinase does not interfere with 
its normal role in the development of the kidneys and enteric nervous system (Smith-
Hicks et al. 2000). The development of tumours in MEN 2B transgenic mice has 
previously been postulated to be sensitive to gene dosage. In contrast to MEN 2B knock-
in mice, the MEN 2B-Ret overexpressing mice harbour a multiple transgene under the 
control of a heterologous promoter, which may account for the difference in the 
development of MTC.  
 
1.3.5 GDNF signalling 
 
1.3.5.1 Ret-dependent GDNF family signalling 
 
GDNF family members bind to specific GFRα co-receptors, but all of them activate Ret. 
Ret is unable to bind GDNF on its own but can be activated in a complex with GFRα1 
(Jing et al. 1996; Treanor et al. 1996). Other members of the GDNF ligand family bind to 
Ret with the aid of different members of (GFRα1-4) of the GFRα family of GPI-liked 
coreceptors (reviewed by Airaksinen et al. 1999). The lipid rafts are membrane structures 
of sphingolipids and cholesterol packed into moving platforms within the lipid bilayer. 
Raft microdomains may help to compartmentalise sets of signalling molecule at both 
sides of the plasma membrane, allowing them to interact with each other in a regulated 
manner, and at the same time preventing them from interacting with proteins excluded 
from rafts (Simons and Toomre 2000).  It was discovered that inactive Ret is localised 
outside rafts (Paratcha et al. 2001, reviewed by Saarma 2001). Furthermore, GDNF signal 
transduction is dependent on intact rafts, because cholesterol depletion with methyl-β-
cyclodextrin decreases GDNF signalling. Current experimental data favour the existence 
of two models for the Ret activation including in cis signalling and in trans signalling 
mechanisms. In cells coexpressing Ret and GFRα1, which is located in lipid rafts 
(Poteryaev et al. 1999; Trupp et al. 1999), GDNF induces and/or stabilises the formation 
of a complex between the two receptors, then interacts with two molecules of Ret and 
induces their homodimerisation and autophosphorylation at tyrosine residues (in cis 
signalling, see Fig. 7) (Paratcha et al. 2001; reviewed by Saarma 2001). GFRα1 recruits 
Ret to lipid rafts only following GDNF stimulation, resulting in the association of Ret and 
Src.  
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Figure 7. Schematic presentation of the GFRα1 inducing Ret homodimerisation in 
cis and autophosphorylation at tyrosine residues. 
 
The overlapping and complementary expression of GFRαs with each other, with ligands, 
and with Ret, suggests that the functions of the GDNF family can be regulated in various 
ways. GFRα1 is widely expressed in the absence of Ret, suggesting alternative roles for 
“ectopic” sites of GFRα1 expression. GFRα1 also binds its ligand and activates Ret 
when provided exogenously in soluble form or immobilised on agarose beads (Treanor et 
al. 1996; Yu et al. 1998; Qiao et al. 1999). GFRαs are usually bound to the plasma 
membrane but a specific cleavage by a putative phospholipase or protease produces 
soluble forms of these co-receptor (Paratcha et al. 2001). Thus, another possibility is that 
GFRα1 may also function in a non-cell-autonomous manner to capture and concentrate 
diffusible GDNF family ligands from the extracellular space and then present these 
factors in trans to affect Ret-expressing cells (in trans signalling, see Fig. 8) (Paratcha et 
al. 2001; Saarma 2001). Activation of Ret in trans also results in the mobilisation of Ret 
to lipid raft membranes even in cells that lack endogenous GPI-anchored GFRα1 
(Paratcha et al. 2001). Upon activation in cis, Ret is recruited to membrane rafts by a 
rapid extracellular mechanism, likely driven by its affinity for newly formed GDNF/ 
GFRα1 complexes, independently of its tyrosine kinase activity. In contrast, recruitment 
in trans is delayed, sustained, and requires an active Ret tyrosine kinase, suggesting the 
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involvement of intracellular events (Paratcha et al. 2001). Downstream signalling after 
stimulation in trans is at least as efficient as that induced in cis and potentiates 
downstream signalling, neuronal survival and differentiation (Paratcha et al. 2001). 
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Figure 8. Schematic presentation of GFRα1 inducing Ret homodimerisation in trans 
and autophosphorylation at tyrosine residues. 
 
Based on the existing data it is assumed that also other members of the GDNF family, 
NRTN, ARTN and PSPN interact with their cognate co-receptor and activate Ret 
similarly to GDNF. 
 
1.3.5.2 The downstream pathways of Ret signal transduction  
 
Since Ret was discovered as the functional receptor for GDNF, the intracellular signalling 
through Ret has been extensively studied (reviewed by Airaksinen et al. 1999; Hayashi et 
al. 2000; Takahashi 2001). Like other tyrosine kinases, upon ligand binding, Ret can 
activate various signalling pathways including RAS/extracellular signal-regulated kinase 
(ERK), phosphatidylinositol 3-kinase (PI3K)/AKT, p38 mitogen activated protein kinase 
(MAPK) and c-Jun N-ternimal kinase (JNK) pathways (See Fig. 9; Airaksinen et al. 
1999; Trupp et al. 1999; Hayashi et al. 2000; Takahashi et al. 2001). It is well known that 
these signals are transmitted via phosphotyrosines present in the intracellular domains of 
activated receptors. Ret autophosphorylates its tyrosine residues Tyr-905, Tyr-1015, Tyr-
1062 and Tyr1096, which serve as docking sites for the transduction effectors GRB10, 
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phospholipase Cγ (PLCγ), SHC/SNT (FRS2)/Enigma, and GRB2, respectively (reviewed 
by Hayashi 2000; Takahashi 2001). The former three tyrosines are conserved in all three 
Ret isoforms but tyrosine 1096 is present in the long isoform only. Among these Tyr 
residues, Tyr 1062 has a critical role in signalling initiation during embryogenesis and 
tumorigenesis, serving as a docking site for protein complexes (reviewed by Hayashi et 
al. 2000; Takahashi 2001). All of the RAS/ERK, PI3K/AKT, p38MAPK and JNK 
pathways are activated mainly through tyrosine 1062 that is a binding site for SHC 
adaptor proteins (reviewed by Hayashi et al. 2000; Takahashi 2001). After binding of 
SHC to tyrosine 1062, SHC further associates with GAB1/2 adaptor proteins and 
GRB2/SOS complex, leading to the activation of PI3K/AKT and RAS/ERK signalling 
pathways, respectively. SNT/FRS2 is a lipid anchored docking protein with a 
phosphotyrosine-binding (PTB) domain, and it may be involved mainly in activation of 
the RAS/ERK signalling pathway. The binding affinity of SHC and SNT/FRS2 to Ret 
was different among the three isoforms, their binding affinity to the middle isoform Ret 
was significant lower compared to the short and long isoforms. The p38MAPK, JNK 
pathways are also activated through tyrosine 1062. Phosphopeptide maps have showed 
that the autophosphorylation of Ret, found in MEN 2B, differs from that of the wild type 
and MEN 2A-Ret protein suggesting that also their downstream targets may differ (Liu et 
al. 1996). Some of these targets have now been identified (Bocciardi et al. 1997).  
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Figure 9. Schematic presentation of known or proposed intracellular Ret-binding 
proteins. Ret activates several intracellular pathways typical of receptor tyrosine kinase 
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signalling, including Ras-MAPK, phosphoinositol-3-kinase (PI3-K), Jun N-terminal 
kinase (JNK), and p38MAPK. According to Hayashi et al. 2000 and Takahashi 2001. 
 
1.3.5.3 Ret-independent GFRα1 signalling 
 
Recently it was found that a Ret-independent pathway of GDNF signalling may occur in 
lipid rafts (Poteryaev et al. 1999; Trupp et al. 1999). In cultured dorsal root ganglia 
neurones isolated from E18 Ret-deficient mice, GDNF can induce a rapid activation of 
Src-type kinases as well as MAPK (Poteryaev et al. 1999). Soluble GFRα1, which does 
not have GPI-anchors, cannot transduce the signal in response to GDNF binding in Ret-
deficient cells. Therefore lipid rafts are believed to play a key role in Ret-independent 
signalling. It remains unknown whether this has relevance in vivo and whether other 
tyrosine kinase receptors, instead of Ret, are involved in the Ret-independent GFRα 
signalling. 
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2. AIMS OF THE STUDY 
 
The aims of this thesis were to study the biology and pathology of GDNF family 
signalling in spermatogenesis and pathogenesis of testicular tumours. In particular, to 
compare the different roles of GDNF and NRTN in spermatogenesis and tumour 
development. 
 
The specific aims were: 
 
• To study the role of GDNF and NRTN in spermatogenesis. 
 
• To clarify the properties and developmental features of the spermatogonial cells 
arrested by the overexpression of GDNF. 
 
• To characterise the GDNF-induced testis tumours and study the pathogenetic role 
of GDNF signalling in seminomatous GCTs. 
 
• To study the downstream molecular mechanisms mediating the biological and 
pathological functions of GDNF in the testis. 
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3. MATERIALS AND METHODS 
 
3.1 DNA constructs and production of transgenic mice 
 
3.1.1 pEFBOS-hGDNF mice and pEFBOS-NRTN mice 
 
Full-length human GDNF (Genebank accession number: L15306) was cloned into the 
XbaI site of the PEF-BOS vector under the human EF-1α promoter in the sense 
orientation (Mizushima and Nagata 1990). The correctness of the construct was verified 
by sequencing, and GDNF expression was verified by Cos cell transfection and Western 
blotting. Transgenic mice were produced by microinjecting the 2.7 kb PvuI-HindIII 
fragment of the construct, which contains the EF-1α, hGDNF insert and polyadenylation 
signal, into the pronuclei of newly fertilised FVB mouse eggs as described (Hogan 1994). 
Southern blotting with a human GDNF cDNA probe identified the founders and the 
offspring of the transgene-positive mice by PCR from tail DNA. Primers for human 
GDNF were from Exon 1 (5'-TGT CGT GGC TGT CTG CCT GGT GC-3') and Exon 2 
(5'-AAG GCG ATG GGT CTG CAA CAT GCC-3'). Five different founder lines with 
different transgene copy numbers were used in the study. 
 
Mouse NRTN cDNA (Genebank accession number U78109) was cloned into the XbaI 
site of the pEF-BOS vector under the human EF-1α promoter in the sense orientation 
(Mizushima and Nagata 1990). The correctness of the construct was verified by 
sequencing. The 2.5 kb fragment containing the EF-1α promoter, NRTN cDNA and 
polyadenylation sequences was released from the construct with HindIII and PvuI and 
injected into the pronuclei of newly fertilised mouse eggs to produce transgenic mice as 
described above. Transgene positive mice were identified by PCR from tail DNA using 
primers TTCTCCTTGGAATTTGCCCTT and AAAGTTCTCGAAGCTCCACCG 
(product 338 bp). The copy number of the integrated transgene in different transgenic 
lines was determined by Southern blotting hybridisation with mouse NRTN cDNA probe. 
Five lines from different individual founders with various copy numbers of the transgene 
were used in the study. The FVB inbred strain mice were used for generating transgenic 
mice. 
 
3.1.2 GDNF+/- mice 
 
The GDNF deficient mouse strain was previously generated by homologous 
recombination to replace the exon-3-derived coding sequences (amino acids 52 to 1991) 
(Pichel et al. 1996). The wild-type GDNF allele was detected by PCR using the primers 
5' –CCA GAG AAT TCC AGA GGG AAA GGT C and 5' -CAG ATA CAT CCA CAC 
CGT TTA GCG G. The targeted GDNF allele was identified by PCR utilising the primers 
5' –GAT CCC CTC AGA ACT CGT and 5' –CTG TGC TCG ACG TTG TCA CTG. The 
homozygous mice (GDNF-/-) die within 24 hours after birth due to the lack of kidneys 
and intestinal innervation (Pichel et al. 1996). Spermatogenesis was analysed using 
heterozygous (GDNF+/-) mice and wild type littermates. 
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3.2 Germ cell live morphology  
 
Seminiferous tubules were dissected and squashed on preparation slides with PBS buffer. 
Microscopy analysis of live cells was carried out as described (Parvinen et al. 1997). 
 
3.3 Histology, immunohistochemistry, cell proliferation and apoptosis  
 
For histology, freshly dissected testes and epididymides were fixed in Bouin's solution or 
4% paraformaldehyde for 2-24 hours depending on the size of the biopsy, processed in 
paraffin, cut at 5-7µm and stained with hematoxylin/eosin. Rat monoclonal antibodies to 
EE2 (1:200) (Koshimizu et al. 1995, provided by Dr. Y. Nishimune), Tra98 (1:1000) 
(Tanaka et al. 1997, provided by Dr. Y. Nishimune), and GATA1 (1:50) (Santa Cruz 
CA.) were incubated on the deparaffinised sections overnight followed by PBS washes, 
anti-rat IgG secondary antibody at 1:500, and the standard biotin-streptavidin-peroxidase 
labelling procedure according to the manufacturer's instructions (Vector Laboratories, 
Inc. CA.). Species-crossreactive rabbit polyclonal antibodies to GDNF (1:500; Santa 
Cruz, CA.), c-Kit (1:200; Santa Cruz, CA.), and c-Ret (1:500; IBL, Fujioka, Japan) or a 
polyclonal Ret antibody provided by Dr. M. Santoro (1:100; Viglietto et al. 2000) were 
incubated for 48 hours at + 4 oC, after PBS washes followed by anti-rabbit IgG secondary 
antibody at 1:500 incubation and biotin-streptavidin-peroxidase labelling detection as 
mentioned above. To assay cell proliferation, the mice were injected intraperitoneally 
with bromodeoxyuridine (BrdU) and 5-fluoro2’-deoxyuridine (FrdU) cocktail 
(Amersham) at a concentration of 1-2ml/100g body weight in PBS. After 2 hr, the mice 
were sacrificed by neck dislocation and autopsied; testes were removed and fixed in 
Bouin's solution. Testes were processed in paraffin; 7µm sections were cut and 
deparaffinised. BrdU incorporation was detected by indirect immunofluorescence with 
mouse monoclonal antibodies to BrdU (Amersham) followed by rhodamine-conjugated 
goat anti-mouse IgG (Jackson Immunoresearch Laboratories, Inc.). Apoptotic cells were 
detected in deparaffinised sections with ApopTag in situ cell death detection kit 
(Intergen) according to the manufacturer's instructions. 
 
3.4 Total RNA isolation and Northern blotting 
 
Total RNAs were isolated with the TRIZOL Reagent kit (Life Technology) according to 
the manufacturer's protocol and 30µg of total RNA was used in each lane. Northern 
blotting was carried out according to standard protocol (Sambrook et al. 1989) The 
probes (listed in Table 2) of mouse NRTN, rat GFRα2, mouse GDNF, mouse full-length 
c-Ret 3.3 kb, and mouse GFRα1 cDNA labelled with [α32p]dCTP were used in the 
hybridisation. The filters were exposed overnight to a FujiBAS phosphoimager screen 
and the screen was scanned and analysed in the FujiBAS-1500 phosphoimager (Photo 
Film Co. Lt, Japan).  
 
3.5 In situ hybridisation 
 
Radioactive In situ hybridisation was performed as described (Wilkinson and Green 
1990). Antisense and sense cRNA probes (listed in Table 2) were synthesised using 
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appropriate RNA polymerases and 35S-labelled UTP. Hybridisation temperature was 
52oC and autoradiography slides were exposed at +4oC for 2-4 weeks. The counter stain 
for the histological structure was made with hematoxylin staining. The slides were 
photographed with an Olympus Provis microscope equipped with a CCR camera 
(Photometrics Ltd). In PhotoShop 4.0 program, the dark field images were inverted, 
artificially stained red and combined with the bright field images. 
 
Nonradioactive in situ hybridisation was performed by using the digoxigenin-UTP 
labelled Ret and GFRα1 cRNA probe (see Table 2), paraffin testis sections were used, 
and the hybridisation temperature was 70oC. After hybridisation washes, the alkali 
phosphotase conjugated anti-digoxigenin antibody was used for the signal detection, 
followed by a colorimetric detection with reagents NBT and BCLP (X-Phosphate). 
 
Table 2. Probes used in in situ hybridisation and Northern hybridisation 
Probe Size Nucleotides Accession number Used in 
human GDNF 
mouse GDNF 
mouse Ret 
mouse Ret 
mouse GFRα1 
rat GFRα2 
mouse NRTN 
mouse LFng 
mouse Notch 1 
mouse Notch 2 
mouse 3ß-HSD 
mouse WT1 
636bp 
328bp 
3348bp 
684bp 
777bp 
2016bp 
1000bp 
866bp 
573bp 
570bp 
360bp 
1400bp 
full coding region 
exon 3 
1-3348 
2534-3217 
1-777 
full length cDNA 
full length cDNA 
1-866 
3901-4474 
4546-5116 
1323-1686 
full coding region 
L15306 
U36449 
X67812 
X67812 
AF012811 
AF003825 
U78109 
NM 008494 
NM 008714 
NM 008715 
AY046512 
M55512 
I-III 
I, II 
I 
I- IV 
I, III, IV 
IV 
IV 
III 
III 
III 
III 
III 
 
 
3.6 Immunoprecipitation and Western blotting for GDNF and NRTN proteins 
 
Freshly dissected testes were homogenised and lysed in high salt lysis buffer (300 mg 
protein/ml; high salt lysis buffer: 1M NaCl, 100 mM Tris-HCl, pH 8. 2 % BSA, 4 mM 
EDTA, 0.2 % Triton X-100, 2 mM PMSF, 1 mM sodium orthovanadate and 1 protease 
inhibitor cocktail tablet/10 ml (Complete, Mini EDTA, Boehringer Mannheim)). The 
lysates were immunoprecipitated with a rabbit polyclonal antibody to human recombinant 
GDNF peptide that crossreacts with mouse GDNF (R&D Systems) and Protein A-
Sepharose. The immunoprecipitates were run on a 20 % sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Hybond ECL 
nitrocellulose membranes (Amersham Life Science). The membranes were blocked with 
5 % BSA and immunoprecipitated GDNF was detected with a species-crossreactive 
rabbit polyclonal antibody to GDNF (Santa Cruz Biotechnology) at room temperature for 
2 hours. Detection was accomplished by using anti-rabbit secondary antibody conjugated 
to horseradish peroxidase (Sigma) and ECL chemiluminescence (Amersham) according 
to the manufacturer's instructions. 
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Testes were homogenised in the same high salt buffer as described above. The proteins 
were separated on 20% SDS-polyacrylamide gel, blotted on Hybond ECL membrane 
(Amersham), and probed with the rabbit polyclonal anti-NRTN antibody (Chemicon) at 
1:2000 dilution. Signals were detected by an ECL plus kit (Amersham, RPN 2132). 
 
3.7 DNA and karyotype analysis 
 
Flow cytometric analysis of the DNA contents of testicular tumour cells was performed 
by FACScan flow cytometry (Becton Dickinson) after ethidium bromide labelling of the 
nuclei (CellFIT Cell-Cycle Analysis version 2.01.2). Mouse spleen cells served as diploid 
cell controls. Karyotyping was done either from frozen tissues or 60 µm sections of 
paraffin embedded material. 
 
3.8 Immunoprecipitation and Western blotting of phosphorylated Ret 
 
Homogenisation of samples (either freshly dissected or frozen tissues) was performed in 
lysis buffer (50mM HEPES, 1% Triton X-100, 50mM sodium chloride, 50mM sodium 
fluoride, 10mM sodium pyrophosphate, 1% aprotinin, 1mM 
phenylmethylsulfonylfluoride, 0.5mM sodium vanadate). After 30 min incubation on ice 
the homogenate was centrifuged at 13,000g for 2 minutes, and the supernatant was 
analysed by either immunoprecipitation-Western blot or Western blotting. The lysates 
were immunoprecipitated with rabbit polyclonal antibody to human Ret cross-reacting 
with mouse Ret (Viglietto et al. 2000) (the Ret antibody was a gift from Dr. M. Santoro, 
University of Naples, Italy), run on a 7.5% SDS-PAGE, and blotted on Hybond ECL 
membrane (Amersham). Ret protein was detected by the Ret antibody and the 
phosphorylation of Ret was detected by monoclonal phosphotyrosine antibody 
(Transduction Laboratories), and the signals were detected by an ECL plus kit 
(Amersham, RPN 2132). 
 
3.9 MAPK and AKT phosphorylation assays  
 
Total protein lysates mentioned above were separated on a 12% SDS-PAGE, blotted, and 
probed with polyclonal antibodies to phosphorylated forms of either ERK1/2 (Promega) 
or AKT (protein kinase B) (New England Biolabs). The blots were then reprobed with the 
antibodies, which recognise both the phosphorylated and unphosphorylated forms of 
ERK1/2 (Promega) or AKT (New England Biolabs). The optical density of the bands was 
determined using a phosphoimager and a TINA program. 
 
3.10 Germ cell isolation and transplantation 
 
3.10.1 Depletion of host testis by gamma irradiation 
 
NMRInu/nu nude mice were anaesthetized and testes were irradiated using a Philips 
Orthovolt (0.5 mm Cu filter). A 2 cm diameter tube was used to confine radiation to the 
testes and their immediate surroundings. Fractionated doses of 1+4, 1½+8, 1½+12 and 
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1½+16 Gy were given with an interval of 24 h. For evaluation of the extent of depletion, 
testes were harvested after 3 months, fixed in Bouin’s solution and embedded in paraffin.  
 
In a minimum of 200 tubule cross sections the presence of germ cells was assessed and 
tubules were scored as containing endogenous spermatogenesis when spermatogonia or 
in addition later stages were present. Testes that had been withdrawn into the abdominal 
cavity out of the irradiation field during irradiation were not included in the analysis. For 
transplantation, mice were used 1 month after irradiation and testes were harvested 2 
months after transplantation. 
 
3.10.2 Preparation of donor cells 
 
Germ cells were isolated from GDNF-overexpressing or wild type mouse testes, of which 
the correct genotype was confirmed by PCR of tail DNA. Briefly, testes were 
decapsulated and after tearing apart the tubule fragments, subjected to two successive 
enzymatic treatments of 1 mg/ml trypsin, hyaluronidase and collagenase and 1 mg/ml 
hyaluronidase and collagenase, respectively, in MEM containing 0.12% sodium 
bicarbonate, 4 mM L-glutamine, single strength nonessential amino acids, 100 IU-100 
µg/ml penicillin-streptomycin, 40 µg/ml gentamycin and 15 mM HEPES. Cells were 
separated from remaining tubule fragments by centrifugation at 30 g and, after filtration 
through 77 and 55 µm nylon filters, pelleted and loaded onto a Percoll discontinuous 
density gradient. The purity of the cell suspensions was assessed by Nomarski optics, 
cells with a high nucleus-to-cytoplasm ratio and one or more distinct nucleoli being 
characterised as spermatogonia. Fractions with a purity of at least 40% were washed, 
counted and resuspended to a concentration of cells equivalent to 106 germ cells/ml. 
Aliquots of 20 µl of the germ cell suspensions were kept on ice until transplantation. 
 
3.10.3 Transplantation 
 
Germ cell suspensions (20 µl) were transplanted via efferent duct microinjection (Ogawa 
1997) into recipient rete testes and seminiferous tubules, one month after local 
fractionated irradiation. Testes were analysed after two months, a time period previously 
shown to allow for full reinitiation of spermatogenesis (Brinster and Zimmerman 1994). 
Host mice were sacrificed by CO2 asphyxia and testes were fixed in Bouin’s solution.  
 
3.10.4 Statistical analysis 
 
Data are presented as mean±SEM. Statistical analysis was performed by nonparametric 
ANOVA. P<0.05 (two–tailed) was assumed to indicate statistical significance. 
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4. RESULTS  
 
4.1 mRNA expression of GDNF family ligands and receptors in normal mouse testes 
 
By Northern blotting and in situ hybridisation, we found that, among the GDNF family 
ligands, GDNF and NRTN were expressed in normal testis (I, IV). ARTN and PSPN were 
not detectable by in situ hybridisation (unpublished data), although the coreceptor 
GFRα4 for PSPN is expressed prominently in the pachytene spermatocytes in testis 
(unpublished data, Lindahl et al. 2000). We therefore focused our study on the expression 
of GDNF, NRTN, and the expression of their ligand-binding receptors GFRα1, GFRα2, 
and Ret tyrosine kinase. Northern analysis showed a strong band for GDNF and its 
receptors GFRα1 and Ret in the neonatal testis and a low density band after the second 
postnatal week (I), whereas NRTN and GFRα2 were highly expressed after puberty (IV). 
In situ hybridisation showed that both GDNF and NRTN were expressed by Sertoli cells, 
while their receptors were expressed by germ cells (I, IV). The GDNF receptors GFRα1 
and Ret were expressed in a small subset of spermatogonial cells which might include 
putative spermatogonial stem cells (I), these cell are flattened on the basement 
membrane, mostly singly or paired shown by nonradioactive in situ hybridisation (Fig. 
10). 
 
 
 
Figure 10. The mRNA expression of Ret and GFRα1 in the normal adult testis 
detected by nonradioactive in situ hybridisation. Arrows point to the positive cells. 
 
4.2 mRNA and protein expressions of GDNF and its receptors in pEFBOS-hGDNF 
transgenic mice 
 
The expression of GDNF protein of pEFBOS-hGDNF construct was detectable in 
immunoprecipitation-Western blotting from the supernatant of the culture media of the 
transfected Cos cells. We generated several transgenic mouse founder lines with various 
copy numbers of transgene (I). The expression profile of the transgenic GDNF was 
screened by Northern blot hybridisation and the expression was restricted to the testis (I. 
Results 
 
 
41 
Web Figure 2). A ~1.0 kb transgene transcript was constantly expressed from the 
neonatal stage throughout adulthood, but the expression was low in the first two postnatal 
weeks (I). The elevated protein levels of GDNF were verified from the transgenic mouse 
testis by Western blotting (I). In the transgenic testis, the mRNA levels for GDNF 
receptors GFRα1 and Ret were constantly upregulated (I, III). By Western blotting, the 
increased Ret protein and phosphorylation levels were detected in the arrested 
spermatogonial cells (data not shown) and in tumour cells in the GDNF-overexpressing 
transgenic mice (III). Immunolocalisation of Ret showed a wider expression than Ret 
mRNA expression. Ret proteins are localised in spermatogonia and earlier spermatocytes 
in wildtype littermates (II), and in the arrested spermatogonial and tumour cells in 
transgenic mice (I, IV).  
 
4.3 Testicular phenotype in GDNF+/- mice  
 
The GDNF-deficient mice generated by Pichel et al. (1996) die in the first postnatal day. 
Haploinsufficiency of the GDNF gene for kidney development with unilateral renal 
agenesis or rare dysagenesis has been observed in the heterozygous (GDNF+/-) mouse 
(Moore et al. 1996; Pichel et al. 1996; Sánchez et al. 1996). The GDNF+/- mice were 
fertile, though the histological analysis of testis revealed approximately 50% atrophic 
seminiferous tubules with germ cells depletion or Sertoli cell-only (I). In testes of 7-9 
weeks old mice, spermatids or spermatozoa were present in most atrophic seminiferous 
segments, but the spermatogenic cells including spermatogonial cells were rarely present, 
if not completely absent. The BrdU labelling showed very few mitotic spermatogonial 
cells in the basal compartment of the atrophic segments that had not yet progressed to 
Sertoli cell-only (I). At old age, atrophic tubules become Sertoli cell-only.  
 
4.4 Testicular phenotype in pEFBOS-hGDNF transgenic mice  
 
The transgenic mice with testis-restricted overexpression of GDNF were healthy, and no 
abnormalities were found in any tissues, except for the testis. Testicular morphology of 
these mice was normal in neonates. After 2 to 3 weeks of age, a chimeric histological 
pattern was observed. Tubular cross sections not only showed normal spermatogenesis 
but also displayed large cell clusters. The cells in the clusters were first characterised as 
type A spermatogonia by morphological analysis of live cell (I. Web Figure 3) and by 
histology showing only little heterochromatin (I). The cluster cells expressed 
spermatogonial markers EE2 (I) and Tra98 (data not shown). Further clonal 
characterisation showed that spermatogonial cells in the clusters were likely 
undifferentiated spermatogonia, because of the absence of the synchronised mitotic or 
apoptotic figures of these cells; the cluster cells were mostly singly or in small clones in 
pairs, groups of four, and eight. C-kit is an antigen of differentiating spermatogonia 
(Schrans-Stassen et al. 1999). The cluster cells were negative for c-kit (I. Web Figure 4). 
 
The cell proliferation was analysed by bromodeoxyuridine (BrdU) incorporation. After 
the first postnatal week in mice, the normal spermatogonial proliferation displays a 
segmental pattern in tissue cross-sections. In transgenic mouse testes this stage-specific 
cell proliferation was disrupted, the cells within clusters from every segment were 
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labelled (I). The average proliferation indexes of spermatogonia in 100 transsections of 
wildtype and transgenic tubules were not significantly different, and the peak 
proliferation index was higher in wild type than in transgenic mice (I). TUNEL label for 
apoptosis cells showed that the transgenic mice had more apoptotic germ cells after 2-3 
weeks (I). Moreover, in response to a differentiating signal (retinoic acid), 
spermatogenesis was partially restored in transgenic mice and the cells in clusters were 
rapidly induced to undergo massive apoptosis (I).  
 
The somatic cells of seminiferous tubules were normal as compared to the wild type 
testes in several respects. Sertoli cells showed no significant alteration in their number, 
and expressed GATA1 (I. Web Figure 4). The Sertoli-Sertoli cell tight junctions were 
formed in transgenic mice (I). The interstitial cells displayed hyperplasia. However, 
serum T and FSH levels were not different between transgenic and wild type mice 
(unpublished data). Non-metastatic testicular tumours were occasionally developing at 
the age of 7 months and regularly in old GDNF-overexpressing transgenic mice after the 
age of one year. 
 
4.5 Transplantation of GDNF-expressing germ cells  
 
Analysis of endogenous repopulation of germ cell in irradiated testes was performed 3 
months after irradiation (II). In the irradiated mice, a radiation dose-dependent decrease 
in the amount of tubule cross sections containing spermatogenic cells was found. For the 
immunodeficient NMRI nude mice, the strain intended as recipient for transplanted germ 
cells, the dose of 1½ +12 Gy resulted in a depletion of spermatogenic cells in 97±1%  
seminiferous tubules (n=6).  
 
Transplantation of germ cell suspensions isolated from GDNF overexpressors resulted in 
the formation of spermatogonial clusters in all recipient testes. Clusters were of variable 
size and could be recognised by the accumulation of A spermatogonia-like cells with a 
high nucleus-cytoplasmic ratio and a relative paucity of heterochromatin. Clusters and 
more advanced stages of spermatogenesis were found in the same tubule cross sections 
(II). These more advanced germ cells did not proceed beyond pachytene spermatocytes 
(II). In addition to cluster-containing tubules, tubules that contained only a rim of 
spermatogonial cells were found (II). The basal stretch and clustered spermatogonia 
formed by the transplanted transgenic germ cells expressed Ret protein (II) and 
transgenic GDNF mRNA (data not shown).  
 
In the testes of the two mice transplanted with wild type cells, neither clusters nor rims of 
spermatogonial cells were noted (data not shown). Here, normal spermatogenesis was 
found in 24.5% and 20.5% of the seminiferous tubules, respectively, and germ cells in 
these tubules usually had advanced to the pachytene spermatocyte stage, in line with 
previous transplantation studies. 
 
4.6 Characterisation of testicular tumours in old pEFBOS-hGDNF transgenic mice 
 
Old transgenic mice with overexpression of GDNF in undifferentiated spermatogonia 
developed malignant testicular tumours. The characterisation of the tumour type is 
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presented in (III). 56% of the tumours were bilateral. Most tumours appeared at around 1 
year of age, though the earliest case was identified in a 7 month-old mouse.  
 
All tumours were histologically uniform. They were composed of round-shaped cells 
with scant cytoplasm, and fibrous bands between tumour nodules were commonly 
present, but no large clusters of lymphocytes were observed. The mitotic index of the 
tumours was constantly high (~10 mitotic figures/40 x magnification), and the mitotic 
figures were often atypical. No distant metastases were found by autopsy and histological 
analysis.  
 
Tumour cells expressed germ cell markers EE2 and Tra98, but were negative for Leydig 
cell and Sertoli cell markers (3β-HSD and WT1). In the histochemical staining for 
alkaline phosphotase, the tumour cells showed a strong enzymatic reactivity. In addition, 
the enzyme activity was also seen in a few cells in the spermatogonial clusters of young 
transgenic mice. Other molecules characterising both tumour cells and spermatogonial 
cells in the clusters of young transgenic mice were Notch signalling molecules, i.e. 
Notch1, Notch2 and lunatic fringe (L-Fng).  
 
Tumour cells expressed the transgenic GDNF , GFRα1 and Ret as detected by in situ 
hybridisation. Elevated levels of hyperphosphorylated Ret protein were shown by 
immunoprecipitation-Western blotting. We also found increased levels of phosphorylated 
AKT (protein kinase B) and MAPK (Erk1/Erk2) in the tumour cells.  
 
The DNA contents of tumour cells as analysed by flow cytometry exhibited an aneuploid 
karyotype. A distinct triploid peak was always observed, whereas a considerable number 
of tumour cells appeared to be hypodiploid. No peak at the tetraploid or higher levels was 
found. The atrophic tumour-free testes from the transgenic mice (at the age around 3-10 
months) showed diploid DNA content in flow cytometric analysis although the tripolar 
cells were occasionally observed.  
 
 
 
4.7 Testis deficiency in pEFBOS-NRTN transgenic mice 
 
In the transgenic mice overexpressing NRTN in testis, only a partial penetrant and 
transient testicular phenotype was observed (IV). Spermatogenic defects were observed 
in each of the five transgenic lines at the age of 3-5 weeks. In some transgenic mice, 
round spermatids and pachytene spermatocytes degenerated in some seminiferous 
tubules, while simultaneously in others spermatogenesis preceded normally. In other 
transgenic mice, the rete testis was dilated, and the layers of spermatids and late 
spermatocytes were reduced in all seminiferous tubules. After 5 weeks of age, no 
abnormalities were found in spermatogenesis anymore and the NRTN overexpression 
mice were fertile, even though the transgene expression continued during adulthood, as 
evidenced by Northern and Western blotting. No testis tumours were observed in these 
transgenic mice. 
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5. DISCUSSION  
 
5.1 Paracrine regulation of germ cells by GDNF and NRTN  
 
Sperm differentiation can be regulated by local paracrine signals between germ cells and 
Sertoli cells. Sertoli cells, the most important regulators of spermatogenesis, secrete a 
signal molecule, GDNF, acting on the target cells, probably the undifferentiated 
spermatogonia that possess Ret and GFRα1, the receptors for GDNF. Therefore, the 
reciprocal interplay of GDNF from Sertoli cells and its receptors on spermatogonial cells 
fulfils the criteria for a paracrine signalling system for regulating spermatogonial 
differentiation. According to the sites of mRNA expression for the receptors for GDNF, 
the target cells for GDNF are a small subgroup of undifferentiated spermatogonia 
including the putative spermatogonial stem cells (I, Fig. 10). However, in situ 
hybridisation is insensitive when a certain mRNA has low levels of expression. Whether 
there is low expression of Ret mRNA in other cell types is not clear. In fact, Ret proteins 
were detected by immunohistochemistry also in early spermatocytes in addition to the 
basal spermatogonial population (II). A low level of transcription coupled with a highly 
efficient rate of translation might explain this. It may also be due to Ret proteins being 
allocated to the daughter cells during cell divisions, or being directly transferred between 
the germ cells through the intercellular bridges. Therefore it cannot be excluded that 
GDNF might affect a larger range of spermatogonial cell types.  
 
Sertoli cells also produce another member of the GDNF family, NRTN, after puberty. Its 
high affinity coreceptor GFRα2 is expressed at the same time in spermatids and weakly 
in spermatocytes. A possible paracrine interaction between Sertoli cells and germ cells 
may take place via the interplay of NRTN and GFRα2. However, Ret expression was not 
detected in the GFRα2 expressing cells by in situ hybridisation. It might be that a low 
expression of Ret is not detectable in these cells. It is also possible that NRTN signals 
through a Ret-independent signalling pathway. The biology and function of a Ret-
independent GFRα1 signal pathway have been demonstrated recently (Poteryaev et al. 
1999; Trupp et al. 1999), but possible Ret-independent signalling via GFRα2 remains to 
be identified. The transcripts of GFRα2 are smaller in the testis (1-2 kb, IV) than in the 
somatic tissue (4kb, Baloh et al. 1997). The identity of GFRα2 transcripts in testis is 
unknown. However, one is big enough to code for the mature protein when compared to 
the length of the coding area of the gene (Baloh et al. 1997). Whether this transcript 
encodes for a functional protein needs to be studied in the future.  
 
5.2 GDNF regulates spermatogonial self-renewal and differentiation 
 
Normal stem cell renewal and differentiation should be in the balance. Excess self-
renewal over differentiation would reduce the seminiferous epithelium and enhance stem 
cell formation. If differentiation prevails, the stem cells would deplete themselves, 
leading to seminiferous tubules with only Sertoli cells (reviewed by de Rooij 2001). 
 
Many factors are proposed to regulate spermatogonial cell divisions. The focus has been 
on the molecules involved in the differentiation of Aal into A1 spermatogonia (reviewed 
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by de Rooij and Russell 2000; de Rooij 2001). However, the molecular control of self-
renewal and differentiation of stem cells has remained enigmatic. Now we have shown by 
loss-of-function and overexpression transgenic models that the dosage of GDNF may 
regulate the cell fate decision of undifferentiated spermatogonia. Low dosage GDNF 
favours the differentiation of spermatogonia, high dosage favours the self-renewal. The 
haploinsufficiency of GDNF in GDNF+/- mice led to a depletion of tubular germ cells 
including stem cells, leading to approximately 50 percent of the tubules with Sertoli cells-
only. However, in the GDNF+/- mouse testis, the first wave of spermatogenesis 
proceeded in the degenerating tubules, as evidenced by the presence of spermatids and 
spermatozoa. We assume that the stem cell self-renewal is reduced due to the decreased 
GDNF dosage, with differentiation exceeding self-renewal leading to the depletion of 
seminiferous epithelia. In the opposite situation, when the GDNF dosage is increased, 
differentiation of spermatogonia is inhibited. Tubules in 3-week-old GDNF-
overexpressing mice contain large clusters of undifferentiated spermatogonia. The 
transplantation of these clustered cells to a wild type host mouse suggested that the arrest 
of spermatogonial differentiation is donor cell-intrinsic and is caused by deregulated 
autocrine GDNF signalling.  
 
GDNF is a small molecule, which normally is secreted by Sertoli cells. As no Sertoli cell-
specific promoter is available at the moment, GDNF could not be targeted to the cells that 
normally express it. Therefore, one should note that the GDNF overexpression mouse 
does not recapitulate the normal paracrine action of GDNF, and instead, an autocrine 
signalling loop is formed in the spermatogonia that express both the transgenic GDNF 
and the receptors for GDNF. Unlike SCF, in addition to the soluble form secreted from 
Sertoli cells, the Sertoli cell membrane-bound isoform of SCF is also crucial for the 
regulation of germ cell development (Mauditt et al. 1999). No evidence has been 
presented for the existence of a membrane-bound isoform of GDNF protein. We thus 
assume that the germ cell targeted expression of GDNF may mimic the GDNF protein 
secreted from Sertoli cells. The cells which express the receptors Ret and GFRα1 are 
evidently the GDNF targets. A small subset of spermatogonia, very likely including 
putative the stem cells, are the primary target for GDNF, because they express both Ret 
and GFRα1. The morphology and nature of small clonal size for the cells within clusters 
(I: no intercellular bridges, most singly, a few in pairs or small chains) suggest that the 
clustered cells arrested by GDNF are undifferentiated cells including the putative stem 
cells. Moreover, the capability of these cells to colonise and repopulate the host 
seminiferous tubules after transplantation suggests that they have stem cell properties. 
Thus the spermatogonial stem cell is at least one, if not the only, target for GDNF 
signalling. 
 
5.3 NRTN in spermatogenesis 
 
NRTN and GDNF overexpressing mice show different phenotypes. Unlike the GDNF- 
overexpressing mice, the NRTN mice show no accumulation of spermatogonia, they have 
only a low penetration of spermatogenic defects, and when present, these are transient 
and recover after the first spermatogenic wave, and therefore the mice are fertile. In 
contrast to the function of GDNF as a regulator of spermatogonial differentiation, NRTN 
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may affect the development and survival of spermatocytes and spermatids. The 
phenotype of the dilated rete suggests that NRTN might also regulate fluid production 
and reabsorption. Therefore, proper expression of NRTN might be important for normal 
spermatogenesis.  
 
The distinct functions of GDNF and NRTN might result from the non-overlapping 
distribution of the ligand-binding GFRα1 and GFRα2 receptors. Because the testis 
phenotypes of GDNF and NRTN overexpressing- and deficient-mice are completely 
different, biologically significant cross talk between NRTN and GRFα1, and on the other 
hand between GDNF and GFRα2, is unlikely. GDNF and NRTN employ the same 
signalling receptor Ret. However the Ret receptor is only colocalised with the cognate 
ligand-binding coreceptor GFRα1, but not GFRα2. Since we have not seen Ret mRNA 
and protein in the spermatids and late spermatocytes, either the Ret levels are very low in 
these cells or we are dealing here with Ret-independent, GFRα2 signal transduction. One 
more alternative, NRTN may also act upon an unknown transmembrane receptor to 
regulate germ cell development and fluid metabolism. 
 
 
5.4 Promotion of seminomatous tumours by targeted overexpression of GDNF 
 
5.4.1 Cell proliferation, differentiation and apoptosis  
 
Since large numbers of spematogonial cells are formed in GDNF-overexpressing mice 
during the third postnatal week, it is logical to assume that GDNF may promote cell 
proliferation, and prevent these cells from differentiation and apoptosis. Therefore, these 
cells accumulate and form clusters. However, in normal spermatogenesis the cell density 
is strictly controlled by an unknown regulatory mechanism(s), which triggers apoptosis. It 
has been suggested that Sertoli cells actively regulate the optimal number of 
spermatogenic cells (reviewed by de Rooij and Loc 1987; de Rooij 2001). Apoptosis was 
started to increase during the two-third weeks, but the peak apoptosis appears at four 
weeks of age in these transgenic mice. The delay for eliminating the cells in the clusters 
suggests that GDNF may prevent the cells from entering apoptosis. Why are the clustered 
cells eventually eliminated from the luminal compartment? The occurrence of high levels 
of apoptosis correlated to the formation of the blood-testis barrier. After the formation of 
the blood-testis barrier, spermatogonia are normally located in the basal compartment 
outside the barrier. Thus, the reason for the disappearance of the clusters might be the 
misallocation of cells where the nutritional and biochemical environment is not optimal 
for supporting their survival. The blood-testis barrier may hinder the transgenic 
spermatogonial cells from forming new clusters intruding into the lumen. Instead, these 
spermatogonial cells preferentially spread in the basal compartment at adulthood. This 
rim of spermatogonia is unable to differentiate due to the constant overexpression of 
GDNF, but they do not die either. The prevention of apoptosis and differentiation of these 
cells may raise the risk of tumour transformation. Indeed, the mice developed testicular 
tumours regularly at the age of one year. 
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5.4.2 Hypothetical mechanism(s) for the development of testicular tumour 
 
The regular development of seminomatous germ cell tumours suggests a common 
mechanism for this type of tumour formation. In addition to the oncogenesis of MEN 2-
Ret, oncogenic mutations of many receptor tyrosine kinases are well known. However, 
protein-tyrosine kinases (PTKs) and the downstream kinases are important regulators of 
intracellular signal-transduction pathways. Perturbation of PTK signalling by mutations 
and other genetic alterations results in deregulated kinase activity and malignant 
transformation. The lipid kinase PI3-K and some of its downstream targets, such as the 
protein-serine/threonine kinases AKT and p70 S6 kinase, are crucial effectors in 
oncogenic PTK signalling. Oncogenic conversion of protein kinases results from 
perturbation of the normal autoinhibitory constraints on kinase activity (reviewed by 
Blume-Jensen and Hunter 2001). The MEN 2 cancer syndromes are critically dependent 
on the activation the PI3 kinase/AKT (Segouffin-Cariou and Billaud 2000; De Vita et al. 
2000; Murakami et al. 1999). The overexpression of GDNF induced up-regulation and 
hyperactivation of Ret receptor tyrosine kinase (III). Ret tyrosine kinase and its 
downstream effectors including MAP kinases (Erk1/2) and AKT are constantly activated 
in tumour cells. Thus the mitogenic effects of MAP kinase and the antiapoptotic effect of 
AKT may be initial risk factors for tumour formation. AKT promotes cell survival by its 
inhibitory effect on cell apoptosis. Gene inactivation of akt1 has led to the increase of 
germ cell apoptosis, especially spermatogonial apoptosis (Chen et al. 2001). Therefore, 
the hyperactivity of AKT in the spermatogonial cells in GDNF-overexpressing transgenic 
mice may play a role in the oncogenic transformation of these cells. MEN 2 transgenic 
mice had a variable latency period for the development of medullary carcinoma. This 
finding supported the view that additional genetic alterations are required for malignant 
transformation of thyroid C cells (reviewed by Takahashi 2001). Ret cooperates with 
RB/p53 inactivation in a somatic multiple-step model for murine thyroid cancer (Coxon 
et al. 1998). This finding suggests that the development of a murine neuroendocrine 
tumour requires mutational dysregulation within both receptor tyrosine kinase and 
nuclear tumour suppressor gene pathways.  The second hit(s) of the malignant 
transformation in GDNF overexpressing transgenic mouse testis remains to be identified. 
Mutation or a deregulation of tumour suppressor genes may be the second step required 
for the oncogenic transformation.  Retinoblastoma family proteins encompassing pocket 
proteins pRb, p107 and p130, are potentially important regulators of cell growth, 
differentiation and apoptosis. The retinoblastoma susceptibility gene, Rb, was the first 
tumour suppressor gene described. By regulating gene expression, pocket proteins control 
cell cycle progression, cell cycle entry and exit, cell differentiation and apoptosis (Graña 
et al. 1998). Roles of pocket proteins in the control of germ cell proliferation, 
differentiation and apoptosis have been suggested (Yan et al. 2001). They are expressed 
in several cell types in the testis, which include spermatogonia. Interestingly, p130 is 
localised in the undifferentiated spermatogonia (Yan et al. 2001). Whether there is a 
deregulated activation of these proteins during testicular tumour formation will be 
addressed in our future studies. 
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5.4.3 GDNF-induced testicular tumours resembling human seminoma 
 
Several characteristics of the GDNF-induced tumours resemble the classic seminoma 
rather than spermatocytic seminomas. Firstly, the histological features, secondly, the 
triploid karyotype of tumour cells, thirdly, the primordial feature of tumour cells which is 
characterised by the high activity of alkaline phosphotase, fourthly, the possibly origin of 
tumour cells from "CIS" cells. In the transgenic mice, immature gonocyte-like germ cells, 
which seem to be comparable to CIS cells in man, are present before tumours appear. 
Human CIS cells are PLAP positive and are unable to undergo differentiation, slowly 
replacing the seminiferous epithelium (Skakkebaek and Berthelsen 1978, 1981; 
Skakkebaek et al. 1987, 1998, 2000). We found clusters of undifferentiated 
spermatogonia already at two weeks of age and the first microinvasive spermatogonia 
already at seven months of age, further indicating that the pathogenesis of these tumours 
can be traced back to a young age. Tripolar cell divisions and the alkaline phosphotase 
positive cells in the clusters of the young GDNF overexpressing mice may suggest that 
these cells are already transformed, resembling the CIS cells. 
 
Although these experimental murine tumours and human seminomas are similar in 
several respects, there are also differences, such as the high frequency of bilateral 
tumours in mouse (unilateral in man), the appearance of tumours at an old age in mouse 
vs. at young age in man, tumour development in the context of severely distorted 
spermatogenesis in mouse vs. normal spermatogenesis in man, and the absence of large 
lymphocyte infiltrates in mouse while these are present in most but not all classic 
seminomas (Mostofi 1980; Skakkebaek et al. 1987). C-kit is negative in mouse vs 
positive in human seminoma. These differences may suggest species variation in the 
disease. 
 
In addition to the hypothesis that GCTs originate from CISs, it was also proposed that 
perhaps malignant transformation of type A spermatogonia is associated with 
dedifferentiation of adult germ cells so that they revert structurally and functionally to 
more primitive precursor cells (Holstein et al. 1987). This hypothesis has not received 
direct evidence. However, since the majority of the cells are diploid prior to the 
development of testicular cancer, it cannot be absolutely excluded that the tumour cells 
are derived from transformed A spermatogonia by dedifferentiation, although the 
possibility of CIS cell origin is evidenced by the several aspects as discussed above. 
According to another speculation, the target cell type for transformation in germ cells 
may be zygotene-pachytene spermatocytes with replicated chromosomes that express 
wild-type p53, harbour DNA breaks, and may be prone to apoptosis (Chaganti and 
Houldsworth 2000). Our data does not support this hypothesis, because the DNA 
measurement of GDNF-overexpressing transgenic mice show a diploid karyotype and no 
tetraploid DNA content, and histological analysis reveal that no zygotene or pachytene 
spermatocytes were present at the stage prior to the development of testicular tumours. 
Therefore it is unlikely that the tumour cells are transformed from zygotene or pachytene 
cells. Although no triploid content has been observed in flow cytometry analysis, the 
tripolar spermatogonial cells in young as well as old transgenic mice probably represent 
aneuploid cancer precursor cells with triploidy. The number of these cells might be too 
few to be shown by flow cytometry.  
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6. CONCLUDING REMARKS AND PERSPECTIVES 
 
This thesis work reveals novel functions for GDNF and NRTN in the regulation of 
spermatogenesis. The control of cell fate decisions of undifferentiated spermatogonia by 
GDNF renders the molecules affecting GDNF signalling potential targets for developing 
male contraceptives. The GDNF-deficient and overexpressing transgenic mouse lines 
serve as useful tools for studying the pathogenesis of infertility. Furthermore, the 
testicular tumours developing in the GDNF-overexpressing mice resemble human 
seminomatous GCTs. This transgenic mouse line is the first animal model for seminoma 
and therefore serves as a powerful tool to study the pathogenesis of seminoma and to test 
novel therapies and diagnostic methods. 
 
The spermatogonial stem cell transplantation techniques could be used not only for 
conducting basic research of germ cell biology, but also for restoring the spermatogenesis 
of a man who suffers from infertility or gonadal damage after chemotherapy. The 
testicular tumours formed in GDNF-overexpressing transgenic mice are a consequence of 
long term stimulation by a GDNF signal loop in vivo. It is unlikely that spermatogonia 
would undergo transformation during a short term in vitro stimulation. As we have 
discovered, stem cell self-renewal overrides differentiation in GDNF-overexpressing 
transgenic mice. This finding suggests that GDNF may also be useful in vitro for 
multiplying the stem cell population prior to germ cell transplantation, which might be 
beneficial for the patients who need to cryopreserve spermatogonic cells prior to 
oncogenic therapy. However, the risk of cancer should be taken into consideration when 
reintroducing the cryopreserved cells back into the patients. Similar precaution should be 
considered in the development of GDNF-based therapies for the treatment of 
neurodegenerative diseases. 
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